Sitemap
- Health Equity
- Environment
- Employees
- Community Engagement
- Measuring sustainability
- Reports & Guidelines
- Our sustainability strategy
- Business Ethics
- Products & Innovation
- Transparency in Healthcare
- The Sustainables
-
- Smashing it... Sustainably!
- Meat the Future!
- ONE view on sustainability in R&D
- Embracing Sustainability with Green Solvents
- Driving Decarbonization Together!
- The Patter of Tiny (Ecological) Feet
- Safeguarding Human Progress!
- Impacting Society Sustainably!
- Sustainability... with Substance!
- Giving healthcare a personal touch
- The Greener Way To Repel Disease!
- Sustainable By Design
- Advancing Digital Living with Electronics
-
- Media Resources
-
- Innovation thoughts
-
- Leakage Variation with Aspect Ratio in ALD High-k ZrO2 Dielectrics
- Shedding new light onto the structure of ferroelectric hafnium oxide films
- SELECTING A GASGUARD SYSTEM FOR CONTROLLING HEATED SPECIALTY GASES
- LOW-K INTERMETAL DIELECTRICS
- ASSAY MEANS PURITY, RIGHT?
- WORKING WITH CUSTOMERS TO DEVELOP NEW MOLECULES
- Accelerating Analog AI R&D for Neuromorphic Computing Takes Intelligence
- Industry’s First 4-Element ALD Chalcogenide-based OTS for 3D Memory Arrays
- ALD in Confined Spaces
- The Next Revolution in Semiconductor Processing: Atomic Layer Etching
- Videos & Webinars
- Materials Innovation
- Intermolecular® accelerates material innovation
- Special Effect Pigments
- OLED Materials – Thin, Flexible, Breathtaking
- Specialty Gases in Semiconductor Manufacturing
- Safety First – More than 1000 days without incident
- Ultra Bright Liquid Crystals
- Banishing Microplastics in Cosmetics Industry
- Follow us on social media!
- Press releases issued after the publication of ad-hoc releases
- Media Contacts
- Press Kits
-
- Results of the fourth quarter and fiscal year 2024
- Off to a Good Start in Fiscal 2024
- Fiscal 2023: Proven resilience during transitional year
- Group Confirms Forecast for Fiscal 2023 Despite Difficult Market Environment in Q3
- Demonstrating Resilience under Market Pressure
- Group Benefits from Global Diversification in a Challenging Environment
- Our contributions to the fight against Covid-19
-
- A five-point plan against pandemics
- Updates on Covid-19
- How we became a manufacturer of disinfectant
- How the Future Insight Prize supports top scientists
- Global Health in times of Covid-19
- Face shields from a 3D printer
- "We need to look at every single tool we have"
- “We are helping to bring innovative diagnostic test kits to market”
- Definitive Agreement to Acquire Exelead
- Profitable Growth Despite Challenges
- Group Delivers Strong Organic Growth in Q3
- Q2 2022: Group Delivers Robust Growth Despite Headwinds
- Fiscal 2021: Record Growth and Higher Profitability
- Q3 2021: “Big 3” Again Deliver Efficient, Double-Digit Growth
- Strong Second Quarter with Double-Digit Growth Driven by Big 3
- First Quarter of 2021: Great Strength in Challenging Market Environment
- Lab Water Purification
- Access to Medicine
- Future Insight Prize 2019
- CES 2020
- Schistosomiasis Elimination Program
- Q3/2019: Financial Results
- Q2/2019: Merck KGaA, Darmstadt, Germany, Sees Profit Jump in Q2
- Q1/2019: Forecast for Organic Performance in 2019 confirmed
- Q4/2018: Group Achieves 2018 Targets and Is Set for Profitable Growth
- Financial Results 2019: Group Meets all Financial Targets
- Strong first quarter – low impact from Covid-19 to date
- Second Quarter: Group Remains on Course in a Challenging Environment
- Q3 2020: Strong Third Quarter
- CES 2021
- Financial Results 2020: Group Reports Record Results in a Turbulent Year
- Performance Materials is now Electronics
- Discussing future trends in Electronics at CES 2022
- First Quarter: Strong Start into Fiscal 2022
- Subscribe to News Releases
- Unsubscribe from News Releases
- Download Gallery
- News Blackboard
- 2016-01-21 Merck KGaA, Darmstadt, Germany and BrandWatch Technologies Form Long-Term Partnership
- 2016-01-04 Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of...
- 2016-04-14 Merck KGaA, Darmstadt, Germany, Appoints Maya Martinez-Davis as Global Head of Oncology
- 2016-04-19 MilliporeSigma Earns Accreditation for Quality Control of Culture Media
- 2016-02-10 Amazing Lighting Experiences with Materials from Merck KGaA, Darmstadt, Germany
- 2016-04-25 Merck KGaA, Darmstadt, Germany Wins European Investor Relations Awards
- 2016-04-26 First Multi-use Disposable Sterile Connectors for Biopharma
- 2016-02-19 Treasury Team Wins European Prize for Sigma-Aldrich Acquisition Financing
- 2016-04-29 Annual General Meeting of Merck KGaA, Darmstadt, Germany, Approves Dividend Inc
- 2016-08-01 Merck KGaA, Darmstadt, Germany and Nanoco Sign Agreement
- 2016-03-02 Merck KGaA, Darmstadt, Germany, Initiates Phase III Study of MSB11022, a Proposed Biosimilar of Adalimumab, in Chronic Plaque Psoriasis
- 2016-08-02 Merck KGaA, Darmstadt, Germany Invests € 15 million in LC Window Technology
- 2016-12-01 Merck KGaA, Darmstadt, Germany Expands Distribution Agreementwith Roche
- 2016-04-14 Merck KGaA, Darmstadt, Germany, Responds to Legal Claims in the U.S.
- 2016-12-13 Merck KGaA, Darmstadt, Germany Presents Smart LCWindows at BAU 2017
- 2016-04-27 New MilliporeSigma Products Bring Ease of Use to Single-Use
- 2016-01-07 Collaboration on New Liquid Biopsy Technology
- 2016-07-01 Johann Heinrich Merck KGaA, Darmstadt, Germany, Award Goes To Kathrin Passig
- 2016-07-01 Merck KGaA, Darmstadt, Germany and University of Nairobi to Start Medical
- 2016-07-13 Merck KGaA, Darmstadt, Germany, Advances Water Purification Systems with New...
- 2016-06-29 Merck KGaA, Darmstadt, Germany, Receives Frost & Sullivan Award for Meoxal® and Xirallic® NXT Lines
- 2016-07-27 Merck KGaA, Darmstadt, Germany Biopharma Innovation Cup Honors Young Scientists
- 2016-06-28 MilliporeSigma Expands Industry-Leading Emprove® Program
- 2016-06-28 MilliporeSigma to Develop Next-Generation Purification Processes with International Vaccine Institute
- 2016-06-07 MilliporeSigma Announces Survey Results Exploring Biopharma Industry’s Evolving
- 2016-07-18 MilliporeSigma Relaunches Customer Collaboration Centers with New Concept and M Lab™ Name
- 2016-07-19 MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts
- 2016-07-06 Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer
- 2016-05-02 Merck KGaA, Darmstadt, Germany, Expands Production Know-how to Deliver Full...
- 2016-05-11 Merck KGaA, Darmstadt, Germany, Expands Popular Line of ...
- 2016-05-09 Merck KGaA, Darmstadt, Germany, Launches First Commercially Available
- 2016-05-10 Merck KGaA, Darmstadt, Germany, A High-Tech for the Automotive Industry
- 2016-05-09 Merck KGaA, Darmstadt, Germany, and Progyny Extend Collaboration for Eeva®
- 2016-05-04 Merck KGaA, Darmstadt, Germany, at SID: Materials for the Displays of
- 2016-05-04 Merck KGaA, Darmstadt, Germany, Builds on Leading Viral and Gene
- 2016-03-15 Photovoltaic Windows: Energy Efficient and Energy Generating
- 2016-03-29 Merck KGaA, Darmstadt, Germany, CRISPR Epigenetic
- 2016-03-07 Merck KGaA, Darmstadt, Germany, Launches Global Science Education
- 2016-03-08 Merck, KGaA, Darmstadt, Germany, Finishes Record Year 2015 Stronger
- 2016-03-07 Life Science Leader Merck KGaA, Darmstadt, Germany, Launches New Innovations
- 2016-11-16 Jens Frahm and Franz Pischinger Inducted into the Hall of Fame of German Research
- 2016-11-30 Merck KGaA, Darmstadt, Germany, Collaborates with Evotec for Faster Target Iden
- 2016-10-10 Merck KGaA, Darmstadt, Germany, Announces Recipients of Third Annual €1 Million ‘Grant for Oncology Innovation’ Award
- 2016-10-06 Merck KGaA, Darmstadt, Germany, Unveils New State-of-the-Art M Lab
- 2016-07-13 Merck KGaA, Darmstadt, Germany Awards Premio Letterario of Merck KGaA, Darmstadt, Germany in Rome
- 2016-08-03 MilliporeSigma Expands Portfolio of Certified Reference Materials
- 2016-08-01 MilliporeSigma to Provide Provantage® End-to-End Development and Manufacturing Services to Y-mAbs for Lead Antibody Compound
- 2016-08-04 Merck KGaA, Darmstadt, Germany, Lifts Forecast Following Good Second Quarter
- 2016-08-23 Tagore Award India
- 2016-09-30 Merck KGaA, Darmstadt, Germany, Presents Its First Russian Literary Prize
- 2016-09-13 MilliporeSigma Lab Earns ISO Accreditation for Quality Control of Culture Media
- 2016-09-08 MilliporeSigma Launches New Gene Editing Technology to Engineer Virus Resistant CHO Cell Lines
- 2016-09-26 MilliporeSigma Launches Viresolve® Pro Shield H for More Robust, Economical Parvovirus Removal
- 2016-09-19 MilliporeSigma’s New Steritest™ Symbio Pump Accessories Enable Faster, Sterility Testing in Any Setting
- 2016-09-07 Merck KGaA, Darmstadt, Germany, Opens New OLED Materials Production Plant in Darmstadt
- 2016-09-21 Merck KGaA, Darmstadt, Germany, Invests over € 50 million in Flagship Pharmaceutical Packaging Building in Darmstadt
- 2016-09-13 Merck KGaA, Darmstadt, Germany, Strengthens Display Materials R&D in China
- 2016-10-11 Merck KGaA, Darmstadt, Germany, Publishes First International Curiosity Study
- 2016-10-19 Merck KGaA, Darmstadt, Germany Donates 500 Millionth Praziquantel Tablet
- 2016-10-21 Kakehashi Literature Prize Presented in Japan
- 2016-10-05 MilliporeSigma’s Udit Batra Receives CPhI’s ‘CEO of the Year’ Award
- 2016-10-28 Merck KGaA, Darmstadt, Germany, Named as Top Employer by Science Magazine
- 2016-11-11 MilliporeSigma Wins R&D 100 Award for Top Invention
- 2016-11-04 Merck KGaA, Darmstadt, Germany, Invests € 250 Million in Production Value Chain in China
- 2016-11-22 Frosty-brilliant Silver Shine: The Merck KGaA, Darmstadt, Germany, Pigment Innovation Ronastar® Frozen Jewel
- 2016-10-18 Merck KGaA, Darmstadt, Germany, Showcases Innovative Effect Pigments and Processes at K2016
- 2016-11-15 Merck KGaA, Darmstadt, Germany, Raises Profit Forecast for 2016 Following Good Third Quarter
- 2016-12-05 MilliporeSigma to Provide Provantage® End-to-End Services to Acticor Biotech SAS
- 2016-12-08 Merck KGaA, Darmstadt, Germany, Appoints Thomas Möller as new Head of External Communications
- 2016-12-02 MilliporeSigma Launches Parteck® MXP Excipient for Increased Solubility
- 2016-10-13 MilliporeSigma Introduces First Certified Spiking Solution® of Heavy Labeled
- 2016-09-28 Merck KGaA, Darmstadt, Germany, to Present New Research Focused on Hard-to
- 2016-09-22 Merck KGaA, Darmstadt, Germany, and the Royal Health Awareness Society Partner
- 2016-09-08 Merck KGaA, Darmstadt, Germany, is Co-Creating the Cars of Tomorrow
- 2017-01-10 Merck KGaA, Darmstadt, Germany and CLEARink Displays Sign Development Agreement
- 2016-02-15 Merck KGaA, Darmstadt, Germany Presents New Material Advancements for Next Generation Lithography
- 2016-06-09 Accelerator Program of Merck KGaA, Darmstadt, Germany, Expands its Reach to Silicon Valley
- 2016-05-18 Merck KGaA, Darmstadt, Germany, and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
- 2016-10-06 Merck KGaA, Darmstadt, Germany, Defines Blue-Glow Purple as the Effect Color of 2017
- 2016-04-29 Merck KGaA, Darmstadt, Germany, Annual General Meeting 2016: CEO Handover After Ten Successful Years
- 2016-11-07 Merck KGaA, Darmstadt, Germany and Idemitsu Signed Collaboration Agreement in the OLED Material Business
- 2016-04-14 Merck KGaA, Darmstadt, Germany, to Present Data On Comparative Effectiveness of Rebif® versus Oral Therapy at AAN Annual Meeting
- 2016-07-15 Dietmar Eidens Appointed Chief HR Officer (CHRO) of Merck KGaA, Darmstadt, Germany
- 2016-09-22 Merck KGaA, Darmstadt, Germany, Presents Displaying Futures Award for the First Time
- 2016-09-16 Merck KGaA, Darmstadt, Germany, Presents New Data Examining Durable Efficacy with Investigational Cladribine Tablets in Multiple Sclerosis
- 2016-10-31 European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
- 2016-04-05 Merck KGaA, Darmstadt, Germany, and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinoma
- 2017-01-10 MilliporeSigma Expands End-to-End Biodevelopment Centers in North America,
- 2016-11-14 Merck KGaA, Darmstadt, Germany Ranks Fourth in 2016 Access to Medicine Index
- 2016-10-13 Merck KGaA, Darmstadt, Germany, Sets its Sights on 2018 and Outlines Future Strategic Roadmap
- 2017-01-18 MilliporeSigma Launches First Commercial Service to Predict Multiple Sources of
- 2016-06-01 Merck KGaA, Darmstadt, Germany: Belén Garijo Receives Prestigious Career Award
- 2017-01-17 MilliporeSigma Opens Production Facility Exclusively for Meglumine in Spain
- 2016-09-15 "From Glitter to Glamour" – The Merck KGaA’s, Darmstadt, Germany, Pigment Innovation Ronastar® Royal Sparkle
- 2016-05-24 Merck KGaA, Darmstadt, Germany, Showcases Innovative Effect Pigments and Printing Technologies at Drupa 2016
- 2017-01-12 Merck KGaA, Darmstadt, Germany, and Palantir Launch New Healthcare Acceleration
- 2016-05-30 For perfect white – Iriodin® 6111 Icy White Pristine KU26 from Merck KGaA, Darmstadt, Germany
- 2016-09-23 Merck KGaA, Darmstadt, Germany, Appoints Isabel De Paoli as Chief Strategy Officer
- 2016-07-18 Merck KGaA, Darmstadt, Germany, Receives European Medicines Agency Acceptance for Review of Marketing Authorization Application for Cladribine Tablets
- 2016-09-15 Merck KGaA, Darmstadt, Germany, Announces 2016 Recipients of €1 Million Grant for Multiple Sclerosis Innovation
- 2016-09-12 Merck KGaA, Darmstadt, Germany, Presents New Data on the Safety and Durable Efficacy of Cladribine Tablets and Advantages of Early Treatment with Rebif® at the 2016 ECTRIMS Congress
- 2017-01-19 Innovation Award for Organic Photovoltaics at the BAU 2017
- 2017-01-17 Merck KGaA, Darmstadt, Germany, Moves Executives Between Businesses
- 2016-01-19 Merck KGaA, Darmstadt, Germany, Appoints New Executive Board Members
- 2016-03-29 Merck KGaA, Darmstadt, Germany, Presents New Highlights at In-Cosmetics 2016: Make-up Trends, Innovative Protection and Personal Care Concepts
- 2016-07-08 Merck KGaA, Darmstadt, Germany, Launches New High-Temperature Pigment Series for the Ceramics Industry
- 2016-06-30 Merck KGaA, Darmstadt, Germany, Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance
- 2017-01-12 Merck KGaA, Darmstadt, Germany, Drives Business Opportunities in the U.S. to Fo
- 2016-11-02 Merck KGaA, Darmstadt, Germany, Presents Phase II Data on the Safety and Efficacy of Atacicept at the 2016 ACR/ARHP Annual Meeting
- 2016-11-14 Merck KGaA, Darmstadt, Germany Confirm Potential of Atacicept
- 2016-06-06 ASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma
- 2016-10-12 Plastics with 3D Effect: Merck KGaA, Darmstadt, Germany and PolyOne Agree to Collaborate
- 2016-09-12 Merck KGaA, Darmstadt, Germany Announces Recipients of the Grant for Growth Innovation 2016
- 2016-12-05 Ronastar® Red Allure: The elegant, matte pigment innovation from Merck KGaA, Darmstadt, Germany
- 2016-12-15 Xirallic® NXT Cougar Red: The mysterious colorintense pigment innovation from Merck KGaA, Darmstadt, Germany
- 2017-01-12 Merck KGaA, Darmstadt, Germany, Drives Business Opportunities in the U.S.
- 2017-01-11 Merck KGaA, Darmstadt, Germany, Licenses Four Oncology Research and Development
- 2017-02-28 FDA Accepts the Biologics License Application for Avelumab for the Treatment...
- 2017-02-09 Cladribine Tablets Significantly Reduced Brain Atrophy in Patients with...
- 2017-02-02 Merck KGaA, Darmstadt, Germany, appoints Anke Schenkel as Head of Group Control
- 2017-03-02 Allergopharma Opens new Biopharmaceutical Production in Reinbek
- 2017-03-30Merck KGaA, Darmstadt, Germany Advances R&D Strategy through Unique Development
- 2017-03-23 FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved
- 2017-03-22 “Bold & Vibrant”: Merck KGaA, Darmstadt, Germany, Presents Innovations at the E
- 2017-03-09 Merck KGaA, Darmstadt, Germany, Generates Record Sales and Continues to Grow Pr
- 2017-03-16 Merck KGaA, Darmstadt, Germany, Presents Special Effect Products and Concepts a
- 2017-04-24 Merck KGaA, Darmstadt, Germany Divests Biosimilars Business to Fresenius
- 2017-04-12 EU Horizon 2020 Project “HyperOLED” Successfully Launched
- 2016-05-19 Merck KGaA, Darmstadt, Germany, Increases Sales and Earnings in Q1 Following Sigma-Aldrich Acquisition
- 2016-06-08 Merck KGaA, Darmstadt, Germany, Expands its Corporate Ventures Fund
- 2016-11-14 MilliporeSigma Launches Next-Generation Technology for Advanced Live Cell Imaging
- 2017-01-04 MilliporeSigma Acquires BioControl to Strengthen Position in Food Safety Testin
- 2017-03-06 MilliporeSigma Advances Lab Water Purification Technology with Milli-Q® IQ 7000
- 2017-04-06 New Full Spectrum (FS) Phosphors: Merck KGaA, Darmstadt, Germany, Presents Bran
- 2017-04-18 Merck KGaA, Darmstadt, Germany Furthers Commitment Towards Elimination of Schis
- 2016-01-27 Merck KGaA, Darmstadt, Germany, Announces New Biopharma Heads for North America
- 2016-02-16 Karl-Ludwig Kley Receives Weizmann Award in the Sciences and Humanities
- 2016-02-16 Merck KGaA, Darmstadt, Germany, and Weizmann Institute Sign New Framework Agree
- 2016-03-03 Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Announce Combination Trial
- 2016-05-24 Nigeria Receives Record Praziquantel Donation
- 2016-07-08 Your Merck KGaA, Darmstadt, Germany, news subscription: Chemicals is now Life S
- 2016-11-01 Merck KGaA, Darmstadt, Germany, Partners with American Cancer Society to Addres
- 2016-01-15 Merck KGaA, Darmstadt, Germany Announces Favorable UK Court Ruling on Name Use
- 2016-10-17 Merck KGaA, Darmstadt, Germany, Expands Biotech Production Capacity in Spain
- 2016-12-16 MilliporeSigma Wins Life Science Industry Award® for Most Memorable Advertising
- 2016-08-03 MilliporeSigma Expands Portfolio of Certified Reference Materials for Applied
- 2016-12-02 MilliporeSigma Introduces MILLIPLEX® High Sensitivity Panel for Faster, More
- 2016-07-12 MilliporeSigma Expands Excipients Portfolio, Adding Polymers for Sustained Rele
- 2016-06-08 Merck KGaA, Darmstadt, Germany, Expands its Corporate Ventures Fund
- 2016-06-28 MilliporeSigma Expands Industry-Leading Emprove® Program to Include Filtration
- 2016-03-21 MilliporeSigma Introduces IsoBag™ for Faster and Easier Transfer of Contact and
- 2016-11-14 Merck KGaA, Darmstadt, Germany’s Phase IIb ADDRESS II Results Confirm Potential
- 2016-09-14 Merck KGaA, Darmstadt, Germany, Joins DiViNe Consortium to Address Low Yields,
- 2016-09-13 MilliporeSigma Lab Earns ISO Accreditation for Quality Control of Culture Media
- 2016-11-29 FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review
- 2016-10-17 Merck KGaA, Darmstadt, Germany, Expands Biotech Production Capacity in Spain
- 2017-06-04 Merck KGaA, Darmstadt, Germany Strengthens Immuno-Oncology Portfolio through Expansion of Fstar Collaboration including LAG-3/PD-L1 Bispecific Antibody
- 2017-04-28 We are a company driven by a passion for research and discovery
- 2017-04-28 Annual General Meeting of Merck KGaA, Darmstadt, Germany, Approves Dividend Increase
- 2017-05-09 MilliporeSigma Acquires Grzybowski Scientific Inventions to Expand Chemical Synthesis Offering
- 2017-05-17 Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data Highlighting Potential of Avelumab in Challenging Cancers at ASCO 2017
- 2017-05-17 MilliporeSigma Develops Alternative CRISPR Genome Editing Method
- 2017-05-17 Shaping Cancer Care Today and Tomorrow: Merck, KGaA, Darmstadt, Germany, to Present New Data from Rapidly Evolving Pipeline at ASCO 2017
- 2017-05-09 FDA Grants Bavencio® approval for a common type of advanced bladder cancer
- 2017-05-16 MilliporeSigma’s CHOZN® Expression System Selected for Bi-specific Antibody Development by SystImmune
- 2017-05-31 Anyone Can Become More Curious. Is That True?
- 2017-05-12 MilliporeSigma and Stelis Biopharma Open First Joint Bioprocess Scale-up Lab in India
- 2017-05-16 Optimizing the Further Development of the Darmstadt Site
- 2017-05-15 MilliporeSigma Launches Industry’s First Off-the-Shelf Cell Culture Media for Perfusion Processes
- 2017-05-18 Liquid Crystals for New Optical Applications: Collaboration with the University of Leeds
- 2017-05-02 Merck KGaA, Darmstadt, Germany, and Schmid Rhyner AG cooperate on 3D technology for printing with depth effect
- 2017-05-08 Merck KGaA, Darmstadt, Germany, at SID: Future-oriented Materials for Displays and More
- 2017-01-23 Merck KGaA, Darmstadt, Germany, Announces Research Collaboration with Domain Th
- 2017-06-14 MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office
- 2017-06-15 Expand Distribution Agreement with Public Health England
- 2017-06-20 Our Company Creates New Immuno-Oncology Company iOnctura
- 2017-06-22 Pigment Innovation at the Laser World of Photonics 2017
- 2017-06-23 Cladribine Tablets Receives Positive CHMP Opinion
- 2017-06-26 Displaying Futures Award Attracts High Interest
- 2017-06-26 MilliporeSigma adds Chemical Products to Reaxys’ Chemistry Database
- 2017-06-29 Our company and Industry Partners Create New Automotive Coating Effects
- 2017-07-06 Merck KGaA, Darmstadt, Germany, Biopharma Innovation Cup 2017
- 2017-07-05 Our Company Awards its 2017 Grant for Fertility Innovation (GFI)
- 2017-04-25 MilliporeSigma Collaborates with LabCentral to Foster Biotech Startups
- 2017-05-01 MilliporeSigma’s Mobius® 2,000-liter Single-use Bioreactors to Expand Avid Bioservices’ Manufacturing Capabilities
- 2017-05-18 Merck KGaA, Darmstadt, Germany, Continues to Grow Profitably in the First Quarter
- 2017-07-06 Response on European Commission Statement of Objections
- 2017-07-12 Our company Refines Western European Life Science Production Site Network
- 2017-07-21 New Application Laboratory in Shanghai
- 2017-07-21 Avelumab
- 2017-08-03 Second-quarter results 2017
- 2017-08-03 European Patent Office to Grant Merck KGaA, Darmstadt, Germany’s Patent
- 2017-08-03 Executive Board Changes at Merck KGaA, Darmstadt, Germany
- 2017-08-03 Advance Vaccine Development and Manufacturing for Neglected Diseases
- 2017-08-25 Mavenclad
- 2017-08-23 Merck KGaA, Darmstadt, Germany to Exhibit at the IAA for the First Time
- 2017-08-23 Merck KGaA, Darmstadt, Germany Sets Up PMatX Incubator in Israel
- 2017-08-31 Seoul-Biennale
- 2017-08-31 ESMO 2017
- 2017-09-01-HEM-Award-2017
- 2017-09-01 Successful Closing of Biosimilars Transaction
- 2017-09-05 Merck KGaA, Darmstadt, Germany, Prepares Strategic Options for the CH
- 2017-09-07-IAA
- 2017-09-11 GOI Awards ESMO 2017
- 2017-09-11 PM-A new head names Heidi Fagerholm
- 2017-09-11 GOBDA-MOU-signin
- 2017-09-12 Merck KGaA, Darmstadt, Germany, Advances Immunology Pipeline with Evobrutinib
- 2017-09-14 IAA-Successful-Premiere
- 2017-09-18 Recipients of the Grant for Growth Innovation 2017
- 2017-09-21 Bavencio EC Approval
- 2017-09-21 ISAL-Automotive-Lighting
- 2017-09-25 Investors-Darling
- 2017-09-27 Bavencio-Japan-Approval
- 2017-09-28 Capital Markets Day 2017
- 2017-10-03 Merck KGaA, Darmstadt, Germany, invests € 35 Million in site of Bari
- 2017-10-05 Global Initiative
- 2017-10-11 New Life Science Center Burlington
- 2017-10-17 Merck KGaA, Darmstadt, Germany Presents New Clinical Data at ACR Annual Meeting
- 2017-10-19 Carlsbad
- 2017-10-20 Advanced Light Protection Award
- 2017-10-20 Science Top Employer
- 2017-10-24 Crispr Canada Patent
- 2017-10-26 ECTRIMS 2017
- 2017-10-25 LC-Windows-Frost-Sullivan-Award
- 2017-10-25 MS-in-Women-Report-Announcement
- 2017-11-01 Lupus Foundation of America collaboration with Merck KGaA, Darmstadt, Germany
- 2017-11-04 Late Breaking Clinical Data from Phase II Trial of Sprifermin
- 2017-11-09 Third quarter of 2017
- 2017-11-09 NICE Recommends Mavenclad
- 2017-11-09 Displaying-Futures-Tokyo
- 2017-11-17 Top Place to Work
- 2017-11-28 JAVELIN Gastric 300 Study
- 2017-11-30 Merck KGaA, Darmstadt, Germany, Opens Production Facility
- 2017-12-04 Cladribine Approved for Relapsing-Remitting MS in Canada
- 2017-12-05 Fertility Benchtop Incubator GeriTM
- 2017-12-07 Mavenclad Approval Australia
- 2015-01-15 News Archive 2015
- 2017-12-12 Allan Gabor Takes Over Leadership in China
- 2017-12-13 New Partnership to Fight Schistosomiasis
- 2017-12-15 Corporate Affairs Wicklandt
- 2017-12-19 Singapore’s IP Office to Grant Milli’s Patent Application for CRISPR Technology
- 2017-12-21 Avelumab Breakthrough Designation RCC
- 2017-12-20 Collaboration with iCON™
- 2014-01-15 News Archive 2014
- 2013-01-15 Press Releases before 2014
- 2012-01-15 Press Releases before 2014
- 2011-01-15 Press Releases before 2014
- 2010-01-15 Press Releases before 2014
- 2009-01-15 Press Releases before 2014
- 2008-01-15 Press Releases before 2014
- 2018-01-16 ASCO GI Curtain Raiser
- 2018-01-26 New Chief Information Officer
- 2018-02-01 Researching New Highly Efficient OLEDs with Quantum Materials
- 2018-02-05 350th Anniversary
- 2018-02-05 Displaying-Futures-Award
- 2018-02-08 Merck KGaA, Darmstadt, Germany Plans 350 Good Deeds for its Anniversary Year
- 2018-02-13 MilliporeSigma Launches Viresolve® Barrier Capsule Filters
- 2018-02-15 Update on Phase III JAVELIN Lung
- 2018-02-16 Merck KGaA, Darmstadt, Germany, Named One of the Global Top Employers in 2018
- 2018-02-20 ExploreBio
- 2018-02-21 40 mn investment Asia
- 2018-02-22 Nine new signature partnerships
- 2018-02-28 Expanded Seeding Labs Part
- 2018-02-26 MAVENCLAD receives first approval in Latin America
- 2018-03-06-Evobrutinib in Relapsing Multiple Sclerosis
- 2018-03-08 Q4-FY Results of 2017
- 2018-03-13 Changes to Performance Materials Leadership Team
- 2018-03-19 Merck KGaA, Darmstadt, Germany Lights up Luminale 2018 in Frankfurt
- 2018-04-09 Mavenclad Receives First Approval in the Middle East & African Region
- 2018-03-27 Medisafe partnership
- 2018-03-27 Fast-Track Designation for Tepotinib
- 2018-04-12 MilliporeSigma Helps Accelerate Global Access to Affordable Vaccines
- 2018-04-13 Advance Multiple Sclerosis Treatment with MAVENCLAD and REBIF Data at AAN 2018
- 2018-04-17 new single use technologies to advance flexible manufacturing
- 2018-04-17 OARSI Curtain Raiser
- 2018-04-18 MilliporeSigma Wins INTERPHEX Exhibitor Award for Best Technological Innovation
- 2018-04-19 Consumer Health Divestiture
- 2018-04-19 Partnership-UCT-MMV
- 2018-04-23 Patent for CRISPR technology in China
- 2018-04-27 MilliporeSigma Advances Cell Analysis with New Benchtop Flow Cytometer
- 2018-04-27 Annual General Meeting 2018
- 2018-04-27 Annual General Meeting 2018 Part 2
- 2018-05-02 Cladribine Tablets Data in MS Journal Show a Strong Treatment Effect
- 2018-05-02 Corporate Responsibility Report Documents Comprehensive Engagement
- 2018-05-02 Merck KGaA, Darmstadt, Germany to Develop Abituzumab
- 2018-05-03 Ceremony 350
- 2018-05-14 New Liquid Crystal Singles by Merck KGaA, Darmstadt, Germany on the SID 2018
- 2018-05-15 Q1 - 2018
- 2018-05-16 MilliporeSigma to Use Genome Editing in Study of Gut Bacteria
- 2018-05-29 MilliporeSigma Announces Collaboration with Solvias
- 2018-05-16 Merck KGaA, Darmstadt, Germany, data at ASCO 2018 to showcase progress
- 2018-05-22 Merck KGaA, Darmstadt, Germany, Survey Reveals Most Thyroid Disorder Patients
- 2018-05-22 Merck KGaA, Darmstadt, Germany, Ignites Firework of Research Initiatives
- 2018-05-30 World MS Day 2018: Call for Greater Curiosity to Drive Understanding of the Disease and Future Innovation
- 2018-06-03 Merck KGaA, Darmstadt, Germany Presents Update on Tepotinib
- 2018-06-04 Merck KGaA, Darmstadt, Germany Presents Updated Clinical Results for M7824
- 2018-06-04 Update Javelin Merkel 200 Bavencio
- 2018-06-05 Bringing Biotechs Closer
- 2018-06-06 Final Registration REACH
- 2018-06-06 Merck KGaA, Darmstadt, Germany, Enhances Research in Ghana
- 2018-06-11 Update on Tepotinib Phase II Results
- 2018-06-12 Thought Leadership in Ethical Gene Editing
- 2018-06-12-Merck KGaA, Darmstadt, Germany Selects Three Winning Teams for Displaying Futur
- 2018-05-28 Digital Color Card App: Effect Pigments Go Digital
- 2018-06-14 Data on Investigational Cladribine Tablets and Rebif® in RMS
- 2018-06-18 Further Insight into the Efficacy of Investigational Cladribine Tablets
- 2018-06-19 Agreement with HistoCyte Laboratories
- 2018-06-20 China Celebration 350
- 2018-06-20 OLED Lab China
- 2018-07-03 Performance Materials Strategy Update
- 2018-07-17 Merck KGaA, Darmstadt, Germany, Announces Future Insight Prize
- 2018-07-26 Merck KGaA, Darmstadt, Germany receives recommendation for approval in 21 EU co
- 2018-07-26 MilliporeSigma and InnoCore Pharmaceuticals to Improve Patient Compliance with
- 2018-07-30 CladribineTablets FDA filing acceptance
- 2018-08-09 Q2 - 2018
- 2018-08-09 GL Changes
- 2018-08-15 Merck KGaA, Darmstadt, Germany, Awarded Australian CRISPR Nickase Patent
- 2018-09-04 MilliporeSigma Launches Next-Generation Process Technologies for Intensified Dr
- 2018-09-03 Ronastar® Black Allure: Merck KGaA, Darmstadt, Germany, introduces the next new
- 2018-09-10 New Application Labs in Philadelphia Enable Close Collaboration
- 2018-09-11 Positive Phase-III-Studie Bavencio plus Inlyta
- 2018-09-14 Merck KGaA, Darmstadt, Germany, Presents Interdisciplinary Cosmetics Research a
- 2018-09-21 MilliporeSigma Makes Major Investment in New Singapore Laboratory
- 2018-10-02 MilliporeSigma Announces $3,000 Grand Prize Winner of Alfred R. Bader Award for
- 04-10-2018 MilliporeSigma Opens M Lab™ Collaboration Center in São Paulo, Brazil
- 2018-10-08 New Efficacy and Safety Data on MS Portfolio to be Presented at ECTRIMS 2018
- 2018-10-11 Global Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosi
- 2018-10-09 ESMO Curtain Raiser
- 2018-10-10 Up to 10-Years of Follow-up Data Reaffirm Safety Profile of Investigational Cla
- 2018-10-12 MilliporeSigma Recognized with CPhI Awards for Innovative Products
- 2018-10-12 Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy
- 2018-10-16-Merck KGaA, Darmstadt, Germany, Aims to Return to Profitable Growth as of 2019
- 2018-10-17 Merck KGaA, Darmstadt, Germany Inaugurates State-of-the-art Pharma Packaging Ce
- 2018-10-18 MilliporeSigma Announces Agreement to Sell Amnis® Flow Cytometry and Guava® Tec
- 2018-10-22 Merck KGaA, Darmstadt, Germany, Presents Updated Results for Bifunctional Immun
- 2018-10-23 Merck KGaA, Darmstadt, Germany unveils new product brand eyrise™
- 2018-10-30 Merck KGaA, Darmstadt, Germany, Presents First Curious Mind Researcher Award
- 2018-11-05 MilliporeSigma Launches BioContinuum™ Platform for Next-Generation Process Impr
- 2018-11-05 Embracing Carers™ expands support for caregivers worldwide
- 2018-11-06 Merck KGaA, Darmstadt, Germany Debuts at First China International Import Expo
- 2018-11-12 Merck KGaA, Darmstadt, Germany, Paves the Way for its Innovation Hub in Souther
- 2018-11-14 Q3 - 2018
- 2018-11-19 JAVELIN Ovarian 200
- 2018-11-19 Syntropy
- 2018-11-20 Access to Medicine Index 2018
- 2018-11-23 MVentures
- 2018-11-23 Change II at ESMO Asia
- 2018-11-27 MilliporeSigma Wins Two R&D 100 Awards for Innovation in 2018
- 2018-11-28 Euroshareholders Award 2018
- 2018-12-01 Merck KGaA, Darmstadt, Germany, successfully divests Consumer Health
- 2016-08-23 Wenzel to Lead the Surface Solutions
- 2018-12-03 Merck KGaA, Darmstadt, Germany Marks Fifth Anniversary of MDM Shanghai
- 2018-12-06 Merck KGaA, Darmstadt, Germany, in Agreement with Cyclica for AI-augmented Scre
- 2018-12-06 Performance Materials Enables Innovations
- 2018-12-10 CRISPR strategic Alliance
- 2018-12-10-Merck KGaA, Darmstadt, Germany, Announces FDA Orphan Drug Designation
- 2018-12-13 Merck KGaA, Darmstadt, Germany, to Showcase Innovative Architectural Solutions
- 2018-12-21 Price Increase Surface Solutions
- 2018-12-20 Intrexon
- 2018-12-20 Kuraray collaboration
- 2018-12-20 M7824 ODD EMA
- 2018-12-21 JAVELIN Ovarian 100
- 2019-01-15 Best Social Media Award
- 2019-01-16 Merck KGaA, Darmstadt, Germany, Welcomes Ten New Startups
- 2019-01-23 Tencent Partnership China
- 2019-01-24 Vertex DNA PK Licensing
- 2019-01-28 EM-Boards
- 2019-01-30 US Patent Blockchain
- 2019-02-04 MilliporeSigma Awards Grants to Biotechs Tackling Cancer and Cardiovascular
- 2019-02-01 Ecovadis-Rating
- 2019-02-05-m7824
- 2019-02-06 Merck KGaA, Darmstadt, Germany, Named a Global Top Employer
- 2019-02-06 Merck KGaA, Darmstadt, Germany to Expand US Biopharmaceutical R&D Facility
- 2019-02-11 Bavencio-Inlyta-FDA-sBLA
- 2019-02-16 ASCO
- 2019-02-19 First U.S. Patent for Improved CRISPR Genome-Editing Method
- 2019-04-24 MilliporeSigma Introduces New Greener Solvent, Cyrene™
- 2019-02-25 Merck KGaA, Darmstadt, Germany at in-cosmetics 2019
- 2019-02-27 Science and Skincare Industry Meet at 4th DermoCosmetics Foru
- 2019-02-27 Versum
- 2019-03-04 MilliporeSigma Awarded Canadian CRISPR Nickase Patent
- 2019-03-07 Q4/FY Results of 2018
- 2019-03-05 Versum Open Letter
- 2019-03-08 European Medicines Agency Validates Application for BAVENCIO® Plus INLYTA®
- 2019-03-12 Versum Preliminary Proxy Statement
- 2019-03-18 MilliporeSigma- Milli-Q® Connect-Water Purification with Cloud-based Technology
- 2019-03-14 Collaboration with Iktos for Generative Artificial Intelligence (AI) Technology
- 2019-03-19 Collaboration GenScript China
- 2019-03-20 First M-Lab Collaboration Center in Europe
- 2019-03-19 JAVELIN Ovarian PARP
- 2019-03-20 Agreement applicable to the Darmstadt site
- 2019-03-25 First Short-Course Oral Treatment for RRMS in Switzerland
- 2019-03-26 Versum
- 2019-03-28 Merck KGaA, Darmstadt, Germany, Expansion of Capacity for Biotech Medicines
- 2019-03-29 Mavenclad
- 2019-04-04 MilliporeSigma Recognized with INTERPHEX Exhibitor Award for Best New Product
- 2019-04-15 Merck KGaA, Darmstadt, Germany Publishes Corporate Responsibility Report 2018
- 2019-04-12 Versum Definitive Agreement
- 2019-04-26 Wolfgang Büchele Re-elected Supervisory Board Chairman
- 2019-04-26 Merck KGaA, Darmstadt, Germany, Presents Plans for Future Growth to Shareholders
- 2019-04-30 Mavenclad
- 2019-05-02 ESA
- 2019-05-14 Bavencio
- 2019-05-06 IMI
- 2019-05-10-PPII-Data-Further-Highlights-Clinical-Proof-of-Concept-for-Evobrutinib
- 2019-05-14 Q1-2019
- 2019-05-15 ASCO 2019
- 2019-05-20 MilliporeSigma Joins TRANSVAC2 to Advance Vaccine Development and Manufacturing
- 2019-05-22 WHA Life Science
- 2019-05-28-pm-sandmann-weiland
- 2019-05-30-Pioneers-New-Effort-to-See-MS-from-the-Inside-Out
- 2019-05-30 MilliporeSigma Awards Grants to Biotechs
- 2019-06-03 Updated Results for Investigational Therapy Tepotinib
- 2019-06-06 Crystal Do
- 2019-06-04 Quantum Computing
- 2019-06-05 Accelerator
- 2019-06-17 Versum Stockholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
- 2019-06-18 Bond Financing Rating
- 2019-06-20 Best Places to Work
- 2019-06-24 Mavenclad
- 2019-07-01 Merck KGaA, Darmstadt, Germany Places Bonds Amounting to € 2 Billion
- 2019-07-09 Future Insight Prize
- 2019-07-16 Embracing Carers Time Counts
- 2019-07-18 Intermolecular
- 2019-07-18 Broad Institute
- 2019-08-05 UDC PR
- 2019-08-08-Q2-2019
- 2019-08-06 MilliporeSigma Acquires BSSN Software to Accelerate Digital Transformation
- 2019-08-19-crispr-patents
- 2019-08-28-ECTRIMS
- 2019-09-04-Heinrich-Emanuel-Merck-Award-2019
- 2019-09-09 WCLC 2019 Tepotinib
- 2019-09-10-Evobrutinib
- 2019-09-11 Capital Markets Day 2019
- 2019-09-11 Tepotinib Breakthrough Therapy Designation
- 2019-09-11 Capital Markets Day 2019 Update
- 2019-09-20 Intermolecular
- 2019-09-23-Rebif-label
- 2019-09-20 Bavencio-RCC-CHMP
- 2019-09-23 ESMO19 Curtain Raiser
- 2019-09-24 Women with Cancer
- 2019-10-08 Merck KGaA, Darmstadt, Germany, Expands and Modernizes Pigments Production
- 2019-09-27 ESMO Bavencio
- 2019-09-27 Erbitux 1L Approval in China
- 2019-10-04 Schistosomiasis
- 2019-10-07 Pigment Innovations at K2019
- 2019-10-08 JAMA Publication of Phase II Results of Sprifermin
- 2019-10-07 Versum Closing
- 2019-10-10 MilliporeSigma Becomes the First to Use Acoustic Technology for Cell Therapy
- 2019-10-18 Innovation Center Shanghai
- 2019-10-22 Bavencio-MCC
- 2019-10-28 Bavencio-RCC-EC-Approval
- 2019-10-29-Curious Mind Researcher Award Granted
- 2019-11-12 MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec
- 2019-11-08 Bavencio Update JavelinGastric100
- 2019-11-14 Merck KGaA, Darmstadt, Germany, Generates Profitable Growth in Q3 2019
- 2019-11-18 MilliporeSigma Wins R&D 100 Award for First-to-Market Biopharma Purification
- 2019-11-20 Merck KGaA, Darmstadt, Germany, Announces Orphan Drug Designation for Investiga
- 2019-11-26 Japan and Singapore Grant CRISPR Patents to MilliporeSigma
- 2019-12-16 Consumer Electronics Show 2020
- 2019-12-19 CRISPR license to Promega
- 2020-01-06 Bavencio Bladder 100
- 2020-01-09 Bonds
- 2020-01-27 Our company invest in State-Of-The-Art Biotech Development Facility
- 01-30-2020 Merck KGaA, Darmstadt, Germany Donates one Billionth Praziquantel Tablet
- 2020-02-11 MilliporeSigma’s New BrightLab™ Cloud-hosted Software Brings IoT to R&D
- 2020-02-18 MilliporeSigma to Manufacture Elypta’s Liquid Biopsy Kits
- 2020-02-19 Allergopharma
- 2020-02-27 3D Printing of Tablets
- 2020-03-03 MilliporeSigma’s New LANEXO™ System to Improve Lab Productivity
- 2020-03-05 Q4 2019
- 2020-03-13 Bavencio Head and Neck
- 2020-03-16 Ronastar® Dazzling Lights – new pigment by Merck KGaA, Darmstadt, Germany
- 2020-03-16 AGM Announcement
- 2020-03-18 Clinicaltrials Update Company Statement
- Merck KGaA, Darmstadt, Germany, statement on Rebif (interferon beta-1a) donation to INSERM
- 2020-03-25 Tepotinib
- 2020-03-27 RonaCare<sup>®</sup> Balmance Restores Harmony to the Skin
- 2020-03-31 Allergopharma Closing
- HC company statement
- Merck KGaA, Darmstadt, Germany, donates 150,000 Liters of Disinfectant
- 2020-04-07 Second U.S. Patent for CRISPR Gene-Editing Technology
- Merck KGaA, Darmstadt, Germany statement on Rebif® donation to the WHO
- 2020-04-09 1L UC Submission and BTD
- Merck KGaA, Darmstadt, Germany Announces its Support of Jenner Institute Reaching first...
- Merck KGaA, Darmstadt, Germany, is Supporting Darmstadt in the COVID-19 Crisis
- 2020-04-21 Boost to Commercial Viral Vector and Gene Therapy Manufacturing Capacity
- 2020-04-23 Ronastar<sup>®</sup> Blue Lights – new interference pigment
- 2020-04-24 Merck KGaA, Darmstadt, Germany, Acquires OLED Patents for Display Applications
- Merck KGaA, Darmstadt, Germany, To Hold Virtual Annual General Meeting On May 28
- 2020-04-30 MilliporeSigma Accelerates Readiness of Bioprocessing Facility of the Future
- ASCO 2020 Curtain Raiser
- Q1/2020: Quarterly Statement
- China Seed Fund Investment
- Merck KGaA, Darmstadt, Germany Granted U.S. Patents for CRISPR-Cas9 Technology
- Masks-Donation
- ASCO 2020
- New Late Breaking Data at EAN Evobrutinib
- Joined Forces on World MS Day
- Merck KGaA, Darmstadt, Germany, and Baylor College of Medicine Collaboration
- AGM 2020 - Annual General Meeting Approves Dividend Proposal
- New England Journal of Medicine Publishes Primary Analysis of VISION Data for Tepotinib
- 2020-06-02 Merck KGaA, Darmstadt, Germany, Announces Performance Materials Organization
- 2020-06-03 Merck KGaA, Darmstadt, Germany announced its second “Live Cosmetics Conference”
- Strategic Partnership with Guardian Glass
- Powerful New Option for CRISPR Research
- European Medicines Agency Validates Application for BAVENCIO® (avelumab)
- Startup from Innovation Lab Markets First Predictive Maintenance Sensors
- First Clinical Trial of TLR7 and 8 Inhibitor as a Potential Treatment for Severe Symptoms
- FDA Approves BAVENCIO® (avelumab) as First-Line Maintenance Treatment for Patients
- EU-Commission Supplementary Statement of Objections
- AI development with Janssen
- 2020-07-01 MilliporeSigma Advances Bioprocessing with Raman Technology Sensor Acquisition
- New Report Identifies Paths to Pandemic Resilience
- 2020-07-06 MilliporeSigma Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech
- Changes Executive Board
- Opening of Life Science Business’ Largest M Lab™ Collaboration Center in Shanghai
- Stephan Sieber awarded € 1 million Future Insight Prize 2020
- MilliporeSigma Invests $20 Million in New Switzerland Laboratory
- Performance Materials Launches € 100,000 Community Involvement Initiative
- MilliporeSigma’s DOZN™ Green Chemistry Tool Named Top Project of the Year
- Bavencio-UK-NICE
- Statement on Rebif® (interferon beta-1a) contribution to the US National Institute of Allergy and Infectious Diseases for the ACTT 3 trial
- Second Quarter: Group Remains on Course in a Challenging Environment
- Tepotinib File Acceptance FDA 25-08-2020
- Hybrid 2020
- New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting
- Merck KGaA, Darmstadt, Germany Announces € 59 Million ADC Manufacturing Expansion
- Positive Phase II Results for Investigational Sonelokimab (M1095)
- ESMO 2020 Curtain Raiser
- Merck KGaA, Darmstadt, Germany, Well-Positioned for Further Growth
- Bavencio-Bladder-100-NEJM-ESMO
- Merck KGaA, Darmstadt, Germany, Opens State-of-the-art Research Center
- Stefan Oschmann to Hand Over Chair of Executive Board to Belén Garijo in 2021
- Press Release Supplementing Ad-hoc Announcement of September 29, 2020
- Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis
- Merck KGaA, Darmstadt, Germany Celebrates for New Membrane Production Facility
- MilliporeSigma Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara
- New VirusExpress™ Platform Speeds Development of Cell and Gene Therapies
- Healthcare R&D Leadership
- MilliporeSigma Awards Grant to Combined Therapeutics
- Curious Mind Research Award 2020
- 2020-10-28 Merck KGaA, Darmstadt, Germany, Announces € 20 Million OLED Manufacturing Expan
- 2020-10-29 MilliporeSigma Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Te
- 2020-11-06 Merck KGaA, Darmstadt, Germany, Plans to Build a New Electronics Technology Cen
- MilliporeSigma’s Latest Technologies Earn Industry Recognition for Accelerating
- Merck KGaA, Darmstadt, Germany, Announces Out-Licensing Agreement
- Merck KGaA, Darmstadt, Germany, Reports Strong Third Quarter
- Merck KGaA, Darmstadt, Germany, Presents New Sustainability Strategy
- Ronastar® Yellow Allure – New Mass Tone pigment for Matte and Luminous Elegancy
- Tepotinib EMA Validation
- Digitalization of Production: Merck KGaA, Darmstadt, Germany, and Siemens Collaborate
- Merck KGaA, Darmstadt, Germany Announces Partnerships to Advance Materials
- Changes in the leadership team of Performance Materials
- Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
- MilliporeSigma Expands Production Capacities
- Bavencio CHMP
- CES 2021
- FDA Approves TEPMETKO
- Merck KGaA, Darmstadt, Germany, Announces Acquisition of AmpTec
- Digital-Ethics-Advisory-Panel
- Update on the INTR@PID Clinical Program Including Lung 037 Study
- Bavencio 1L UC EU Approval
- Wolfgang Losert to retire
- 2020 State of Curiosity Report
- Partnership for elimination of schistosomiasis in Rwanda
- MilliporeSigma Continues Commitment to Science Education and Equity
- North American Leadership Change in HC
- Merck KGaA, Darmstadt, Germany, and BioNTech Extend Strategic Partnership
- Purchase of facility in Arizona
- Merck KGaA, Darmstadt, Germany, Mourns Hans Joachim Langmann
- 2021-02-15 MilliporeSigma Enhances Design for Sustainability Framework, Offers Customers D
- Embracing Carers
- TINS-Neuroscience
- New analysis from the MAGNIFY-MS study on MAVENCLAD® in patients with RMS
- MilliporeSigma to Manufacture Next-Generation Biotherapeutics for Alteogen
- Merck KGaA, Darmstadt, Germany, Reports Record Results in a Turbulent Year
- Xevinapant
- Performance Materials Is Now Electronics
- New Renewable Energy into the Grid through Virtual Power Purchase Agreement
- i350
- Reporting Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment
- Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Therapies
- EMD Electronics Announces Liquid Crystal-Based Solution for Smart Antennas
- Merck KGaA, Darmstadt, Germany, Advances ATR Inhibitor Berzosertib in Cell Lung Cancer
- Sustainability Report 2020
- Merck KGaA, Darmstadt, Germany, and TU Darmstadt Extend Strategic Research Collaboration
- EMD Electronics Announces Investment of EUR 20 million to Expand its Site in Shizuoka
- Evobrutinib to Demonstrate Reduction of a Key Biomarker
- Annual General Meeting: Shareholders Approve all Agenda Items
- New Data Strengthening Evidence for Continued Safe and Effective MAVENCLAD® Use
- Merck KGaA, Darmstadt, Germany Statement on the Out-licensing Agreement
- EMD Electronics strengthens business model for Surface Solutions in the Nordics
- Merck KGaA, Darmstadt, Germany, raises forecast for full year 2021-04-05-2021
- First Quarter of 2021: Great Strength in Challenging Market Environment
- Merck KGaA, Darmstadt, Germany Announces Changes in Operating Model for Healthcare
- Data Highlight Significant Advances in Cancer Care at ASCO21 for our Oncology Portfolio
- Accelerates Scale Up of Lipids
- Cultured Meat - Research Grants
- Personnel changes to further push science & technology based strategic growth trajectory
- Merck KGaA, Darmstadt, Germany, receives Halal certifications
- Bioelectronics BBraun Neuroloop
- Bioelectronics Inbrain
- New Chief Diversity Officer
- Investments Darmstadt Site
- Future Insight Prize 2021
- Manufacturing for new pediatric medication against schistosomiasis
- Launch New Green Solvents for Photoresist Removal in Chip Production
- Merck KGaA, Darmstadt, Germany, Announces Appointment of Head of China & International ...
- Strong Second Quarter with Double-Digit Growth Driven by Big 3
- Merck KGaA, Darmstadt, Germany, and TU Darmstadt support visionary sustainability projects
- New Statutory Auditor
- Changes in the leadership team of Electronics
- Company Statement Bintrafusp Alfa
- Merck KGaA, Darmstadt, Germany Announces Change in IT Leadership
- Capital Markets Day 2021
- Smart Antenna
- ESMO 2021 Curtain Raiser
- Electronics invests in growth
- New Group Function Sustainability
- Merck KGaA, Darmstadt, Germany, opens second production line for effect pigments
- Sabia Schwarzer Appointed Head of Group Communications, Brand and Corporate Affairs
- Leadership Changes Group Level
- Merck KGaA, Darmstadt, Germany Announces Mutual Decision to End Bintrafusp Alfa Agreement
- Enrolment of Evobrutinib Phase III Clinical Trials
- MilliporeSigma announces the Licensing of Foundational CRISPR Technology to Cellecta, Pavi
- Launch of-Ronacare<sup>®</sup> Epintegrity
- New Viral Vector Manufacturing Facility for Gene Therapy
- New Real-World MAVENCLAD® Data Show
- Evobrutinib-Significant-Reduction-in-Slowly-Expanding-Lesions-in-Patients-with-RMS
- Özlem Türeci and Uğur Şahin Inducted into the “Hall of Fame der deutschen Forschung”
- Merck KGaA, Darmstadt, Germany, Establishes External Expert Committee for Sustainability
- Siemens and Merck KGaA, Darmstadt, Germany, Collaborate to Boost Machine-to-Machine Trust
- MilliporeSigma Announces New Innovation & Capacity
- Merck KGaA, Darmstadt, Germany, raises forecast for full year 2021
- Q3 2021: “Big 3” Again Deliver Efficient, Double-Digit Growth
- New Study Identifies Drivers of Scientific Research Productivity
- Phase III Results for Arpraziquantel
- Merck KGaA, Darmstadt, Germany, Announces New Sector CFO Healthcare
- Katherine Dei Cas Appointed to SEMI North America Advisory Board
- Novel Mechanisms with the Potential to Transform
- First Vaccine Production Facility in Nigeria
- Athinia to Accelerate the Use of AI and Big Data to Solve Critical Semiconductor Challenge
- EMD Electronics Announces $1 Billion Investment in US to Support Semiconductor Customers
- Merck KGaA, Darmstadt, Germany, Expands Corporate Venture Fund M Ventures
- Merck KGaA, Darmstadt, Germany, to Lead BAIQO Quantum Computing Project
- EMD Electronics at CES 2022 – Advancing Digital Living
- Tepmetko receives positive CHMP opinion
- Acquisition-of-Chord-Therapeutics
- Government Contract Award for New Lateral Flow Membrane Production Facility
- Out-licensing Agreement for Osteoarthritis Asset Sprifermin
- Definitive Agreement to Acquire Exelead
- EMD Electronics Announces New Factory in Arizona
- Announcement of New Appointments in Global R&D and Strategy Leadership for Healthcare
- Elevian announced as Winner of North American Advance Biotech Grant
- 1.5 Billionth Tablet of Praziquantel donated
- Launch of new cosmetics ingredients inspired by superfoods
- LS-Org-Announcement
- Bavencio ASCO GU
- Tepmetko-EC-Approval
- Acquisition of Exelead Completed
- New MAVENCLAD® Data at ACTRIMS Forum 2022
- Results of the Fourth Quarter and Fiscal Year 2021
- Annual General Meeting: Approval of all Agenda Items
- Advances in MS Portfolio
- Acquisition of MAST® Platform
- Heinrich Emanuel Merck Award 2022
- ZooMAb® Antibodies Earns ACT Label
- MilliporeSigma Announces Investment of Approximately € 100 Million to Accelerate Single-Us
- Science Based Targets initiative
- Quarterly Statement Q1/2022
- Curiosity Cube® Mobile Lab
- Emanuel Merck Lectureship 2022
- Investment in Manufacturing Expansion - Cork, Ireland
- Merck KGaA, Darmstadt, Germany to Present Latest Research From Oncology Portfolio at ASCO
- Development Programs in Oncology
- Merck KGaA, Darmstadt, Germany, Places Bonds Amounting to €1.0 billion
- Collaboration in Machine Learning Project
- Collaboration with Agilent Technologies
- CDMO Facility to Address Demand for Critical Cancer Therapies
- Q2 2022: Merck KGaA, Darmstadt, Germany, Delivers Robust Growth Despite Headwinds
- Future Insight Prize 2022
- Modular Automation for Laboratories
- Company’s First Lateral Flow Membrane Production Facility in the United States
- New Solar Panels at MilliporeSigma’s Wisconsin Site Add Renewable Energy to Power Grid
- Collaboration for more sustainable gas solutions
- MilliporeSigma Becomes One of the First CDMOs to Provide Full Viral Vector Offering ...
- Merck KGaA, Darmstadt, Germany, announces agreement to acquire chemical business of Mecaro
- Expansion Molsheim
- ESMO 2022 Curtain Raiser
- ESMO 2022 Xevinapant
- New Chief Human Resources Officer
- Biologics Testing Center Shanghai
- Nerviano Collaboration
- Digital Color Measurement
- Millipore CTDMO Services in Martillac
- CNote
- 2018-04-23 Patent for CRISPR technology in China
- Capital Markets Day 2022
- "Hall of Fame der deutschen Forschung"
- MS Portfolio at ECTRIMS
- Digital twin solution for Primary Packaging
- New Data for Evobrutinib
- Launch new cosmetics ingredients
- Quarterly Statement Q3 2022
- Biotheus
- Merck KGaA, Darmstadt, Germany, Invests € 290 Million in U.S. Drug Safety Testing Capacity
- RD Update Call
- European Medicines Agency (EMA) Validates Application for Arpraziquantel
- MilliporeSigma Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition
- MilliporeSigma Signs MoU with Synplogen
- EMD Electronics, to showcase technologies and applications at CES 2023
- Merck KGaA, Darmstadt, Germany Announces Collaboration with Mersana Therapeutics
- Merck KGaA, Darmstadt, Germany, Completes Acquisition of the Chemical Business of Mecaro
- Semiconductor Solutions
- hc-uc-13-02-2023
- EMD Electronics to Showcase Expertise at 2023 SPIE Advanced Lithography & Patterning
- Financial results 2022
- ACTRIMS Forum 2023
- Semiconductor Manufacturing
- Merck KGaA, Darmstadt, Germany Announces First Palantir Foundry Open-source Code Library
- Merck KGaA, Darmstadt, Germany, Presents its Latest Cosmetics Innovations
- Merck KGaA, Darmstadt, Germany, at the European Coatings Show 2023 in Nuremberg
- Merck KGaA, Darmstadt, Germany Strengthens Oncology Franchise
- MilliporeSigma Announces Expanded Partnership with Beyond Benign to Increase Global Access
- Significant Investment in the World’s Largest Integrated Specialty Gases Facility
- Initiation of New Patients on Evobrutinib Paused in the U.S.
- MilliporeSigma Launches Ultimus® Film to Offer Superior Strength and Leak Resistance
- Curiosity Cube
- Annual General Meeting Approves all Agenda Items
- Quarterly Statement Q1/2023
- Changes in Executive Board
- EMD Electronics Expands Renewable Energy Through Virtual Power Purchase Agreement
- ASCO 23 Curtain Raiser
- Merck KGaA, Darmstadt, Germany’s new barrier materials in OLED devices
- MilliporeSigma Increases Commitment to Biosafety Testing With € 35 Million Investment
- Merck KGaA, Darmstadt, Germany, Collaborates with Research Groups Based in Berkeley, CA
- mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers
- MilliporeSigma Announces Proteologix as Winner of its North American Advance Biotech Grant
- U.S. Businesses of Merck KGaA, Darmstadt, Germany, Named a “Best Place to Work (...)
- Future Insight Prize 2023 Awarded to Khalid Salaita for Early Detection of Pandemics
- Lenexa, Kansas L3 Expansion PR
- Q2 2023: Demonstrating Resilience under Market Pressure
- 2023-09-12-Press-Release
- Fertility Benefits
- AI Partnerships in Healthcare
- MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services
- Embracing Carers UN Collaboration
- Merck KGaA, Darmstadt, Germany Releases Its First-Ever DE&I Report
- Merck KGaA, Darmstadt, Germany Presents MAVENCLAD® (Cladribine) Tablets Data
- Merck KGaA, Darmstadt, Germany Presents New Evobrutinib Data
- EMD Electronics Celebrates Opening of New Arizona Factory
- Merck KGaA, Darmstadt, Germany to Present Latest Research from Oncology Portfolio at ESMO
- Merck KGaA, Darmstadt, Germany, to Return to Growth during Fiscal 2024
- Merck KGaA, Darmstadt, Germany, Strengthens Oncology Through Partnership with Hengrui.
- VPPAs for Europe
- Group Confirms Forecast for Fiscal 2023 Despite Difficult Market Environment in Q3
- MilliporeSigma Launches ChemisTwin™, First Ever Digital Reference Material Platform
- Announces Plans for New U.S. Healthcare HQ in Boston
- MilliporeSigma Expands Newest Biologics Testing Center in Shanghai
- Together with p-Chip we close the gap between physical and digital trust layers
- Merck KGaA, Darmstadt, Germany, Strengthens Oncology Portfolio Through Commercialization
- AIDDISON™ drug discovery software
- Collaboration with Acceleration Consortium on Open-Sourcing AI-Driven Experimentation
- Update on Phase III Results for Evobrutinib in Relapsing Multiple Sclerosis
- EMA’s CHMP Positive for Arpraziquantel to Treat Schistosomiasis in Preschool-Aged Children
- EMD Electronics’ material intelligence takes center stage at CES 2024
- Merck KGaA, Darmstadt, Germany, Expands Colorectal Cancer Portfolio with Inspirna
- Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) as a Standard of Care
- Boards of E. Merck KG, Darmstadt, Germany, Newly Elected
- Michael Kleinemeier Chairman of our Supervisory Board until the 2024 AGM
- Fiscal 2023: Proven resilience during transitional year
- The company Invests More Than € 300 Million in New Life Science Production Site in Daejeon
- MilliporeSigma Launches First All-in-One Genetic Stability Assay to Accelerate Biosafet
- MilliporeSigma Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour
- Annual General Meeting Elects New Supervisory Board
- Merck KGaA, Darmstadt, Germany, Invests More Than € 300 Million in New Life Science Resear
- German Federal Minister Robert Habeck visits Merck KGaA, Darmstadt, Germany
- Off to a Good Start in Fiscal 2024
- Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million
- Merck KGaA, Darmstadt, Germany, to Showcase Advances in the Science of Cancer
- MilliporeSigma Launches First Software for Complete Data Traceability in Microbial QC
- Merck KGaA, Darmstadt, Germany’s Oncology Pipeline Poised to Advance Cancer Treatment
- MilliporeSigma Announces Completion of Schnelldorf Distribution Center Expansion
- MilliporeSigma Announces € 62 Million Investment in Quality Control Facility in Germany
- MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance PD research
- Electronics Innovations at Semicon West 2024
- Xevinapant Update
- Non-Binding MoU with Afrigen Biologics
- Future Insight Prize 2024 Awarded to Johns Hopkins University’s Lauren Gardner
- Return to Organic Sales Growth
- Merck KGaA, Darmstadt, Germany, to Acquire Unity-SC
- Merck KGaA, Darmstadt, Germany, to Acquire Unity-SC
- Merck KGaA, Darmstadt, Germany Joins German Research Project "Semiconductor-X"
- MilliporeSigma Announces Signing of MoU with Gene Therapy Research Institution
- Agreement Signed to Sell Surface Solutions Business Unit to GNMI
- Merck KGaA, Darmstadt, Germany: Strong 2nd Quarter, Guidance raised
- Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering
- Merck KGaA, Darmstadt, Germany Announces First Patient Dosed in Phase III Study of Oral
- MilliporeSigma Receives Industry First EXCiPACT Certification
- MilliporeSigma Launches Single-Use Reactor Designed to Accelerate ADC Manufacturing
- Merck KGaA, Darmstadt, Germany Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits
- Merck KGaA, Darmstadt, Germany, and Siemens enter Strategic Partnership
- Merck KGaA, Darmstadt, Germany, and Siemens enter Strategic Partnership
- MilliporeSigma Opens New €290 Million Biosafety Testing Facility in Rockville,Maryland,USA
- Our Business Sectors
- Life Science
- Healthcare
- Electronics
-
- Electronics Glossary
- Contact our Electronics team
- General Terms and Conditions of Merck KGaA, Darmstadt, Germany
- Trademarks
- Newsletter subscription
- Our commitment to sustainability in the electronics industry
- Electronics Business Fundamentals
- Information for Suppliers
- Sustainability
- Culture and Values
- Data Analytics and AI
- Innovation
- Supply Chain Reliability
- Materials and Solutions
- Vibrant Thoughts Blog
-
- We are in it together for fertility
- My Fertility Journey – You are Not Alone
- Further hope to save the Northern White Rhino
- Leave no one behind
- Fertility treatment after 2020
- In Oncology, Advancing Targeted Treatment Starts with Testing
- Connecting the dots in Fertility
- From Challenge Comes Change - International Women´s Day 2021
- Patient 360° Summit 2020 Meeting: Innovating Together
- Model-Informed Drug Discovery and Development (MID3): Harnessing Knowledge through Collaboration to Inform Decision-Making
- Perspective on Addressing the underserved Patient
- Precision medicine: cancer genome and beyond
- Living a Positive Life with Multiple Sclerosis (MS)
- Closing the Care Gap Around the World - World Cancer Day
- Insights from the fifth Annual Patient 360° Summit: How can digital Healthcare be improved to better help Patients?
- Supporting the Head and Neck Cancer Community, Yesterday, Today and Tomorrow
- Hot Topics at ASCO and Beyond: Navigating Key Terms in Medical Oncology
- Collaborating with the Head and Neck Cancer Alliance: How Patient Voices Help Drive Our Innovation
- 6th Annual Patient 360 Summit providing valuable patient insights on personalised healthcare and clinical trial diversity
- WCD 2023: Cancer Doesn’t Care. But We Do.
- The Science of Cancer: Helping More Patients Become Survivors
- The Science of Cancer: Orchestrating a Holistic Approach to Drug Discovery
- Shaping Tomorrow’s Cancer Care Today
- Frontiers in Tumor Immunology
- Navigating the Waves of Discovery
- Emerging Biotech
- Environmental Testing
- Food and Beverage
- Industrial
- Pharma and Biopharma Manufacturing
- Pharmaceutical Research
- Clinical and Diagnostics
- Government & Academic Research
- Cosmetics
-
- Care Solutions
- Color Effects
- Brands
- Services
-
- Application Technology Center
- Formulation Examples
- Beauty Concepts
-
- Made to Enjoy
- Made to Protect
- Made to Inspire
- All Eyes on Silver
- Something to Smile About
- Turning Heads
- Pearlescence Meets Personal Care
- The Root Miracle
- Pure Love
- 20 Shades of Nude
- Not Just On Vacation
- Accentuated Eyes
- We Value Beauty
- Silver Beauty
- Fight Against Digital Aging
- Polish-up Your Nails
- Celebrate Water Saving Formulations
- Regulatory Support
- Safety
- Attestations of Conformity
- RonaFlair® Filler Finder
- Order your pigment samples
- Order your samples
- Contact Us
- latest
- Pharma Quality Control
- Fertility
- Oncology
- Oncology
- Effect Pigments
- Display Solutions
-
- Solutions
-
- Liquid crystals
-
- Liquid crystal display (LCD) technologies
-
- Blue Phase LCD technology
- In-plane switching (IPS) LCD technology
- Multidomain vertical alignment (MVA) LCD technology
- Patterned vertical alignment (PVA) technology for LCDs
- Twisted nematic (TN) technology for LCDs
- Ultra-brightness fringe field switching (UB-FFS) LCD technology
- Vertical alignment (VA) technologies for LCD
- Polymer stabilized vertical alignment (PS-VA) technology
- Self-alignment-Vertical-alignment LCD technology
- Liquid crystal phases
- The History of LC Displays
- Organic light emitting diode (OLED) materials for displays
- Reactive mesogens
- LED Phosphors
- Photoresists
- Silazanes for unparalleled protection
- Our Flexible Platform
- licrivision® Liquid Crystals for Windows
- Our Organic Light Emitting Diode (OLED) Solutions
- Brands
- Latest
- Services
- Contact Us
- Advancing Display
- Functional Solutions
- Neurology & Immunology
-
- Multiple Sclerosis
- MS Inside Out
-
- Understanding the Importance of HCP-Patient Communication
- MS Inside Out means understanding patient needs
-
- Understand Stanca’s Story from the Inside-Out
- Understand David’s Story from the Inside-Out
- Understand Stephanie’s Story from the Inside-Out
- Understand Alfred’s Story from the Inside-Out
- Understand Marco’s Story from the Inside-Out
- Understand Alexander’s Story from the Inside-Out
- Revealing real lives, real stories
- MS Inside Out means exploring innovative pathways
- MS 20/20*
- MS Inside Out Documentary
- World MS Day
- Cardiovascular, Metabolism and Endocrinology
- Pharma Biotech
- Diagnostics
- Academic and Government Research
- #Microbiotiful
- Surface Solutions
- Semiconductor Solutions
-
- Our Offering
-
- Semiconductor Materials
- Delivery Systems & Services
- Product Catalog
- Product not available
- CHEMGUARD® 1000-2000 Automated Chemical Refill Systems
- CHEMGUARD® GEN III BCD 100-200 Bulk Automated Chemical Delivery Systems
- CHEMGUARD® Gen III Model CG350 Automated Chemical Refill System W/Opt. eV Heating
- CHEMGUARD® GENIII 100-426 Series Automated Chemical Delivery Systems
- CHEMGUARD® GENIII 500 Automated Chemical Refill System with Solvent Purge
- CHEMGUARD® GENIII CG010 Series Automated Chemical Refill System
- CHEMGUARD® GENIII CG050 High Flow Bubbler
- CHEMGUARD® GenIII Controller Retrofit
- Emergency Response Containment Vessel (ECRV) Model 5503
- Emergency Response Containment Vessel Model 5501
- Emergency Response Containment Vessel Model 5502
- FLOWMASTER® CMP Chemical Delivery System
- FLOWMASTER® CMP Slurry Delivery System
- FX-30 FOUP FOSB Cleaner
- GASGUARD® Acetylene Delivery System
- GASGUARD® Active Control Phase 1
- GASGUARD® AP11 Controller
- GASGUARD® AP11 Controller Auto Recovery/Auto Restart (ARS)
- GASGUARD® BULK eV Temperature Control System for Y-Cylinders
- GASGUARD® BulkGUARD™ Bulk Gases System
- GASGUARD® Distribution Systems VMB-DVB
- GASGUARD® eV Temperature Control System
- GASGUARD® Gas Delivery Systems
- GASGUARD® Hydrogen Chloride Purification System
- GASGUARD® LED Lighting – Solid State LED Lighting within the cabinet and controller
- GASGUARD® UHP Forming Gas Blender
- GASGUARD® Very High Flow System
- GCS Global Communications System
- Particle-free Ag-ink, ACM-904
- Ormet® TLPS, DAP-481-1
- Local Trending Software for GASGUARD® AP11/Gen III Controllers
- MEGASYS® Services
- OMNI™ Quartzware Cleaner
- QMAC® Quality Monitoring and Control Analytical System
- S-1087 Exhausted Work Station
- S-1088 Exhausted Line Rinse Station
- S-1702 Etch Parts Cleaner
- Turnkey Project Services and Construction Services
- TYPHOON™ S790 Quartzware Cleaner
- VAPORGUARD® Temperature Control System
- Ormet® TLPS, DAP-491-1
- Ormet® TLPS, XCAP-823-1
- Ormet® TLPS, PCB-710
- Dynaflake™ Flake-Form Hot-Melt Polyurethane Cleaner
- Dynasolve® Final Prep Precision Cleaning Solvent
- Dynalube™ Equipment Storage Fluid
- Dynasolve® 100 Cured Urethane and Acrylic Cleaning Solvent
- Dynasolve® 180 Cured Polymer Cleaning Solvent
- Dynasolve® 185 Amine-Cured Epoxy Cleaning Solvent
- Dynasolve® 190A Urethane/Silicone Conformal Coating Removal Solvent
- Dynasolve® 200 Series - 218, 220, 225, 230 Cured Silicone Cleaning Solvents
- Dynasolve® 2000 Cured Polymer Cleaning Solvent
- Dynasolve® 699 Cured Acrylic Cleaning Solvent
- Dynasolve® 700 Series - 711, 715, 750, 760 Cured Polymer Cleaning Solvents
- Dynasolve® CU-5 Cured Urethane Cleaning Solvent
- Dynasolve® CU-6 Urethane Cleaning Solvent
- Dynasolve® CU-7 Cured Polyimide Cleaning Solvent
- Dynasolve® CU-9 Cured Urethane Cleaning Solvent
- Dynasolve® ISO-Neutralizer Liquid Isocyanate Cleaning Solvent
- Dynasolve® M-10 Uncured Silicone Flushing Solvent
- Dynasolve® M-35 Uncured Epoxy Flushing Solvent
- Dynasolve® Mold Cleaner 1000 Urethane Mold Cleaning Solvent
- Poly-Flush® Stereolithography (SLA) 3D Printing Cleaning Solvent
- PUR-FLUSH 100, 200, and 300 Uncured Urethane Flushing Solvents
- UR-AWAY™ FL Uncured Urethane Flushing Solvent
- Uresolve™ 411 Urethane Conformal Coating Removal Solvent
- ACT® 114
- ACT® 273
- ACT® 410
- ACT® 412
- ACT® 690S
- ACT® 690SX
- ACT® 915A
- ACT® 927C
- ACT® 930
- ACT® 935UP
- ACT® 940
- ACT® 970
- ACT® 970T
- ACT® CMIK-S
- ACT® CMI-S
- ACT® EZStrip® 528H
- ACT® NE-111
- ACT® NE-14
- ACT® NE-89
- ACT® XT-1100
- BPS-100
- BPS-106
- BPS-169
- BPS-170
- BPS-600
- BPS-729A
- BPS-729B
- Dynasolve® 219 Cured Silicone Materials Remover
- Dynasolve® FS8320 Semiaqueous Flux Remover for Wafer Level Packaging
- Dynasolve® Pi4310 Polyimide Remover
- DYNASTRIP® 7700 Multipurpose Photoresist Remover
- DYNASTRIP® AP7880T Multipurpose Photoresist Remover
- DYNASTRIP® AP7900A Multipurpose Photoresist Remover
- DYNASTRIP® AP7900C Multipurpose Photoresist Remover
- DYNASTRIP® DL9150 Non-TMAH Multipurpose Photoresist and Post-Etch Residue Remover
- DYNASTRIP® DL9150B TMAH-Free Multipurpose Photoresist and Post-Etch Residue Remover
- Flipstrip™ Multipurpose Photoresist Remover
- NF3 ─ Nitrogen Trifluoride VLSI
- C3F8 ─ Octafluoropropane MEGA-CLASS®
- ACT® BHP851
- AsH3 ─ Arsine ION-X® Dopant Gas Storage and Delivery System
- AsH3 ─ Arsine MEGABIT®
- AsH3 ─ Arsine MEGABIT® III
- BBr3 ─ Boron Tribromide EXTREMA®
- CF4 ─ Carbon Tetrafluoride VLSI
- ClF3 ─ Chlorine Trifluoride SC
- Cl2 ─ Chlorine VLSI
- C4F6 ─ Hexafluorobutadiene nCtrl
- C4F6 ─ Hexafluorobutadiene VLSI
- C2F6 ─ Hexafluoroethane Halocarbon 116
- HCl ─ Hydrogen Chloride MEGA
- ION-X® BF3 ─ Boron Trifluoride ION-X® Dopant Gas Storage and Delivery System
- Xe ─ Xenon
- Kr ─ Krypton
- C5F8 ─ Octafluorocyclopentene
- Phosphine in Argon Mixture
- Phosphine in Hydrogen Mixture
- ION-X® PH3 ─ Phosphine ION-X® Dopant Gas Storage and Delivery System
- PH3 ─ Phosphine MEGABIT® II
- PH3 ─ Phosphine MOCVD
- POCl3 ─ Phosphorous Oxychloride EXTREMA®
- SiCl4 ─ Silicon Tetrachloride
- SiF4 ─ Silicon Tetrafluoride VLSI
- SF6 ─ Sulfur Hexafluoride
- Triethylborate
- CO2 ─ Carbon Dioxide MEGABIT®
- SiHCl3 ─ Trichlorosilane
- NO ─ Nitric Oxide
- N2O ─ Nitrous Oxide VLSI
- SiH2Cl2 ─ Dichlorosilane
- GeH4 ─ Germane
- GeH4 ─ Germane Hydrogen Mixture 10%
- H2Se ─ Hydrogen Selenide UHP
- WF6 ─ Tungsten Hexafluoride Megaclass
- WF6 ─ Tungsten Hexafluoride Semiconductor
- 10% F2/N2 Mixture ─ AIROPAK® F2/N2 10% Fluorine in Nitrogen Mixture - Commercial Grade
- 20% F2/N2 Mixture ─ AIROPAK® F2/N2 20% Fluorine in Nitrogen Mixture - Commercial Grade
- D2 ─ Deuterium VLSI
- Diborane in Hydrogen Mixture
- eF2/N2 (Electronic Grade) 10% Fluorine
- eF2/N2 (Electronic Grade) 20% Fluorine
- Silica wafer polishing CMP slurries: Syton, Mazin product for Wafer Polishing CMP
- Advanced Oxide CMP slurries: STI Selective Oxide CMP, HPD Selective Oxide CMP
- Post CMP Cleans
- Tungsten CMP slurries
- Copper Bulk CMP slurries: Cu Low dishing CMP, Cu High Rate CMP
- Copper Barrier CMP slurries: BAR Tunable barrier CMP
- SoC
- Core resists
- KrF Thick film resists
- Lift-off Resists
- Thick film resists
- DSA
- TARC
- BARC
- ArF Rinse
- EUV Rinse
- Shrink
- Developers
- Edge Bead Remover (EBR)
- BTBAS
- 4MS
- TEOS
- Trimethylsilane
- Alpha-Terpinene
- Diethoxymethylsilane
- CpCo(CO)2
- CupraSelect
- HFAC
- HfCl4 ─ Hafnium tetrachloride
- HtB-Octane
- Octane
- TaCl5
- TAETO
- TBTDET
- TBTEMT
- TDEAT
- TDEAZr
- TDMAHf
- TDMAT
- TDMAZr
- TEMAHf
- TEMATi
- TMA
- WCl5
- ZrCl4
- CBr4 ─ Carbon tetrabromide
- CCl4 ─ Carbon tetrachloride
- DEZn
- DMZn
- TEB
- TEG
- TMB
- TMG
- Trans-LC
- XeF2 ─ Xenon Difluoride
- MoO2Cl2 ─ Molybdenum Dichloride Dioxide
- TiCL4 ─ Titanium Tetrachloride
- CCTBA
- CPMG
- PDMAT
- TMI
- WNBURE
- RS series
- Spinfil® 600
- Spinfil® 800
- HC-100
- Rinse 500
- Thinner 400
- C4F8 ─ Octafluorocyclobutane VLSI
- C2H2 ─ Acetylene VLSI
- C2H2 ─ Acetylene Megaclass
- NH3 ─ Ammonia VLSI
- BCl3 ─ Boron Trichloride
- HCI – SEMI Hydrogen Chloride
- Cl2 – Chlorine MEGA
- PYRIDINE
- Cp-Zr
- Industries served
- Custom Innovation
- Digital Solutions
- Technical Assets
- How can we help?
- Life Science Services
- Science and Lab Solutions
- Process Solutions
- Electronics Product Catalog
-
- Electronics Product Search Results
- Electronics Product Documentation
- 158121 Xirallic® T61-10 WNT Micro Silver
- 158028 Xirallic® T60-10 SW Crystal Silver
- 158029 Xirallic® T60-20 SW Sunbeam Gold
- 158047 Xirallic® T60-21 SW Solaris Red
- 158100 Xirallic® T60-22 WNT Amethyst Dream
- 158062 Xirallic® T60-23 SW Galaxy Blue
- 158092 Xirallic® T60-25 SW Cosmic Turquoise
- 158093 Xirallic® T60-25 WNT Cosmic Turquoise
- 158037 Xirallic® T60-24 SW Stellar Green
- 158030 Xirallic® F60-50 SW Fireside Copper
- 158031 Xirallic® F60-51 SW Radiant Red
- 158230 Xirallic® NXT T260-23 SW Tigris Blue
- 158225 Xirallic® NXT M260-30 SW Leonis Gold
- 158237 Xirallic® NXT F260-51 SW Cougar Red
- 141183 Meoxal® F120-30 CWT Taklamakan Gold
- 141175 Meoxal® F120-58 CWT Wahiba Orange
- 141184 Meoxal® F121-51 CWT Atacama Red
- 158108 Pyrisma® T40-27 SW Color Space Indigo
- 158114 Pyrisma® T81-23 SW Liquid Blue
- 158115 Pyrisma® T81-23 WNT Liquid Blue
- 158116 Pyrisma® T40-23 SW Color Space Blue
- 158132 Pyrisma® T40-20 SW Color Space Yellow
- 158146 Pyrisma® M40-58 SW Ambercup Orange
- 141060 Miraval® 95311 WR Scenic White
- 158217 Colorstream® F20-51 SW Lava Red
- 158015 Colorstream® T20-01 WNT Viola Fantasy
- 158090 Colorstream® T20-02 WNT Arctic Fire
- 158096 Colorstream® T20-03 WNT Tropic Sunrise
- 158103 Colorstream® T20-04 WNT Lapis Sunlight
- 140585 Iriodin® 9612 Silver-Grey Fine Satin SW
- 104472 Iriodin® 9153 Flash Pearl WR
- 104471 Iriodin® 9163 Shimmer Pearl WR
- 102933 Iriodin® 9502 Red-Brown SW
- 102934 Iriodin® 9504 Red SW
- 103551 Iriodin® 9219 Rutile Lilac Pearl SW
- 103558 Iriodin® 9507 Scarab Red SW
- 104540 Iriodin® 9103 Rutile Sterling Silver SW
- 104554 Iriodin® 9605 Blue-Shade Silver SW
- 104597 Iriodin® 9225 Rutile Blue Pearl SW
- 104598 Iriodin® 9215 Rutile Red Pearl SW
- 140500 Iriodin® 97205 Ultra Rutile Platinum Gold SW
- 140503 Iriodin® 97215 Ultra Rutile Red Pearl SW
- 140504 Iriodin® 97217 Ultra Rutile Copper Pearl SW
- 140505 Iriodin® 97219 Ultra Rutile Lilac Pearl SW
- 140506 Iriodin® 97225 Ultra Rutile Blue Pearl SW
- 140507 Iriodin® 97235 Ultra Rutile Green Pearl SW
- 140517 Iriodin® 9235 Rutile Green Pearl SW
- 140524 Iriodin® 9602 Silver-Grey SW
- 140535 Iriodin® 9205 Rutile Platinum Gold SW
- 140539 Iriodin® 9303 Royal Gold SW
- 140650 Iriodin® 9307 Star Gold SW
- 140540 Iriodin® 9505 Red-Violet SW
- 141425 Iriodin® 96107 SW Icy White Lightning
- 104319 Iriodin® 9217 Rutile Copper Pearl WR
- 104797 Iriodin® 9300 Gold Pearl WR
- 104456 Iriodin® 9440 Colibri Blue-Green WR
- 104896 Iriodin® 9444 Moss Green WR
- 104322 Iriodin® 9500 Bronze WR
- 102935 Iriodin® 9524 Red Satin SW
- 104542 Iriodin® 9111 Rutile Fine Satin SW
- 104543 Iriodin® 9323 Royal Gold Satin SW
- 104553 Iriodin® 9525 Red-Violet Satin SW
- 104562 Iriodin® 9221 Rutile Fine Blue SW
- 104564 Iriodin® 9121 Rutile Lustre Satin SW
- 140534 Iriodin® 9201 Rutile Fine Gold SW
- 140536 Iriodin® 9211 Rutile Fine Red SW
- 140538 Iriodin® 9231 Rutile Fine Green SW
- 140543 Iriodin® 9522 Red-Brown Satin SW
- 140576 Iriodin® 9119 Polar White SW
- 140590 Iriodin® 9223 Rutile Fine Lilac SW
- 141081 Iriodin® 9327 Fine Star Gold SW
- 104809 Iriodin® 9520 Bronze Satin WR
- 104216 Iriodin® 355 Glitter Gold
- 106959 Iriodin® 351 Sunny Gold Pearl
- 106967 Iriodin® 153 Flash Pearl
- 141176 Iriodin® 6153 Icy White Flash
- 141107 Miraval® 5401 Royal Twinkle
- 140941 Miraval® 5311 Scenic White
- 141048 Miraval® 5320 Scenic Gold
- 103346 Iriodin® 363 Shimmer Gold
- 103977 Iriodin® 249 Flash Gold
- 103978 Iriodin® 259 Flash Red
- 103985 Iriodin® 289 Flash Blue
- 103986 Iriodin® 299 Flash Green
- 104234 Iriodin® 530 Glitter Bronze
- 104468 Iriodin® 532 Glitter Red-Brown
- 104469 Iriodin® 534 Glitter Red
- 104246 Iriodin® 103 Rutile Sterling Silver
- 106960 Iriodin® 163 Shimmer Pearl
- 104235 Iriodin® 502 Red-Brown
- 104232 Iriodin® 504 Red
- 104231 Iriodin® 500 Bronze
- 140994 Colorstream® F10-51 Lava Red
- 140962 Colorstream® T10-04 Lapis Sunlight
- 140897 Colorstream® T10-03 Tropic Sunrise
- 140838 Colorstream® T10-02 Arctic Fire
- 140648 Colorstream® T10-01 Viola Fantasy
- 141182 Pyrisma® M30-58 Ambercup Orange
- 141102 Pyrisma® T30-24 Color Space Green
- 141128 Iriodin® 6163 Icy White Shimmer
- 140900 Miraval® 5411 Magic White
- 141101 Pyrisma® T30-25 Color Space Turquoise
- 140902 Miraval® 5411 Magic White KU 28
- 140917 Miraval® 5420 Magic Gold
- 141100 Pyrisma® T30-23 Color Space Blue
- 140918 Miraval® 5421 Magic Copper
- 140919 Miraval® 5424 Magic Blue
- 140963 Miraval® 5422 Magic Red
- 140964 Miraval® 5423 Magic Lilac
- 140965 Miraval® 5425 Magic Turquoise
- 140966 Miraval® 5426 Magic Green
- 141106 Miraval® 5400 Luxury Twinkle
- 141116 Miraval® 5402 Pacific Twinkle
- 141438 Miraval® 5430 Cosmic Gold
- 141442 Miraval® 5450 Cosmic Bronze
- 141471 Miraval® 5412 Cosmic Silver
- 141099 Pyrisma® T30-27 Color Space Indigo
- 140971 Iriodin® 6103 Icy White
- 141098 Pyrisma® T30-22 Color Space Violet
- 141097 Pyrisma® T30-26 Color Space Magenta
- 141096 Pyrisma® T30-21 Color Space Red
- 141095 Pyrisma® T30-20 Color Space Yellow
- 141415 Iriodin® 6107 Icy White Lightning
- 104267 Iriodin® 7235 Ultra Rutile Green Pearl
- 104591 Iriodin® 303 Royal Gold
- 104634 Iriodin® 300 Gold Pearl
- 104670 Iriodin® 100 Silver Pearl
- 104898 Iriodin® 600 Black Mica
- 104976 Iriodin® 306 Olympic Gold
- 106822 Iriodin® Brilliant Pearl KU 26
- 140527 Iriodin® 7225 Ultra Rutile Blue Pearl
- 140528 Iriodin® 7219 Ultra Rutile Lilac Pearl
- 140529 Iriodin® 7205 Ultra Rutile Platinum Gold
- 140530 Iriodin® 7217 Ultra Rutile Copper Pearl
- 140531 Iriodin® 7215 Ultra Rutile Red Pearl
- 140646 Iriodin® 305 Solar Gold
- 141056 Pyrisma® T30-00 Pacific Lagoon
- 141057 Pyrisma® T30-01 Royal Damask
- 104787 Iriodin® 183
- 141062 Iriodin® 100 WM 10
- 141063 Iriodin® 111 WM 10
- 141064 Iriodin® 119 WM 10
- 141065 Iriodin® 120 WM 10
- 141066 Iriodin® 123 WM 10
- 141067 Iriodin® 163 WM 10
- 141068 Iriodin® 305 WM 10
- 141070 Iriodin® 504 WM 10
- 141071 Iriodin® 289 WM 10
- 104259 Iriodin® 111 Rutile Fine Satin
- 141459 Iriodin® 6111 Icy White Pristine KU26
- 103936 Biflair® 66 A
- 104611 Biflair® 89
- 140583 Biflair® 83 S
- 103530 Iriodin® 223 Rutile Fine Lilac
- 103947 Iriodin® 211 Rutile Fine Red
- 103948 Iriodin® 201 Rutile Fine Gold
- 103989 Iriodin® 231 Rutile Fine Green
- 104217 Iriodin® 302 Gold Satin
- 104236 Iriodin® 520 Bronze Satin
- 104237 Iriodin® 522 Red-Brown Satin
- 104241 Iriodin® 524 Red Satin
- 104470 Iriodin® 221 Rutile Fine Blue
- 104590 Iriodin® 323 Royal Gold Satin
- 104712 Iriodin® 120 Luster Satin
- 104842 Iriodin® 123 Bright Luster Satin
- 104869 Iriodin® 326 Olympic Gold Satin
- 104959 Iriodin® 119 Polar White
- 106823 Iriodin® 119 Polar White KU 26
- 106824 Iriodin® 123 Bright Luster Satin KU 26
- 141058 Iriodin® 325 Solar Gold Satin
- 141113 Iriodin® 119 WAY
- 141127 Iriodin® 6123 Icy White Satin
- 141465 Spectraval™ Blue
- 141466 Spectraval™ White
- 141469 Spectraval™ Red
- 141470 Spectraval™ Green
- 104779 Iriotec® 8830
- 104781 Iriotec® 8805
- 104782 Iriotec® 8820
- 104783 Iriotec® 8825
- 104786 Iriotec® 8835
- 106825 Iriotec® 8800
- 141083 Iriotec® 8208
- 141412 Iriotec® 8210
- 141414 Iriotec® 8850
- 141428 Iriotec® 8815
- 141434 Iriotec® 8841
- 141467 Iriotec® 8826
- 104913 Iriotec® 7320
- 140975 Iriotec® 7325
- 140990 Iriotec® 7315
- 141157 Iriotec® 7330
- 141468 Iriotec® 7340
- 140700 Iriotec® 9770
- 141086 Iriotec® 9880
- 141156 Iriotec® 9875
- 214042 - DURAZANE® 1033
- 214047 - DURAZANE 1066
- 214328 - DURAZANE 1085
- 214043 DURAZANE 1500 Rapid Cure
- 214044 DURAZANE 1500 Slow Cure
- 214049 - Durazane® 1800
- 585107 Durazane® 2400
- 213603 Durazane® 2200
- 102125 Calcium Thioglycolate trihydrate
- 110152 DHA Plus
- 110150 Dihydroxyacetone extra pure for cosmetic purposes
- 130165 Emblica®
- 105382 Eusolex® 2292
- 105844 Eusolex® 9020
- 111412 Eusolex® HMS
- 105377 Eusolex® OCR
- 108898 Zinc sulfide granules sublimed, about 1-4 mm (ZnS) Patinal®
- 120606 Candurin® Blue Shimmer
- 120617 Candurin® Brown Amber
- 120610 Candurin® Gold Lustre
- 120608 Candurin® Gold Sheen
- 120604 Candurin® Gold Shimmer
- 120623 Candurin® Gold Sparkle
- 120607 Candurin® Green Shimmer
- 120609 Candurin® Light Gold
- 120624 Candurin® NXT Ruby Red
- 120615 Candurin® Orange Amber
- 120613 Candurin® Red Amber
- 120619 Candurin® Red Lustre
- 120605 Candurin® Red Shimmer
- 120622 Candurin® Red Sparkle
- 120600 Candurin® Silver Fine
- 120602 Candurin® Silver Lustre
- 120601 Candurin® Silver Sheen
- 120603 Candurin® Silver Sparkle
- 117060 RonaFlair® B-50
- 117739 RonaFlair® Balance Blue
- 117734 RonaFlair® Balance Gold
- 117786 RonaFlair® Balance Green
- 117732 RonaFlair® Balance Red
- 117777 RonaFlair® Boroneige® SF-12
- 117778 RonaFlair® Boroneige® SF-15
- 117774 RonaFlair® Boroneige® SF-3
- 117775 RonaFlair® Boroneige® SF-6
- 117776 RonaFlair® Boroneige® SF-9
- 117061 RonaFlair® ESQ
- 117311 RonaFlair® Extender W
- 117022 RonaFlair® Fines
- 117789 RonaFlair® Flawless
- 117755 RonaFlair® LDP White
- 117077 RonaFlair® LF-2000
- 117399 RonaFlair® Low Luster Pigment
- 104750 RonaFlair® Mica M
- 117742 RonaFlair® M-Sphere
- 117080 RonaFlair® MTU
- 117100 RonaFlair® N-50
- 117176 RonaFlair® Silk Mica
- 106949 Eusolex® OS
- 117756 RonaFlair® Soft Sphere
- 117731 RonaFlair® Softshade
- 117769 RonaFlair® SynMica M
- 117751 RonaFlair® White Sapphire
- 105373 Eusolex® T-2000
- 105401 Eusolex® T-AQUA
- 105335 Eusolex® T-AVO
- 117488 Colorona® Amber
- 117463 Colorona® Blackstar Blue
- 105338 Eusolex® T-EASY
- 117460 Colorona® Blackstar Gold
- 117464 Colorona® Blackstar Green
- 117461 Colorona® Blackstar Red
- 117405 Colorona® Bordeaux
- 117353 Colorona® Bronze
- 117384 Colorona® Bronze Fine
- 117376 Colorona® Bronze Sparkle
- 117272 Colorona® Carmine Red
- 117404 Colorona® Chameleon
- 117378 Colorona® Copper
- 117385 Colorona® Copper Fine
- 117374 Colorona® Copper Sparkle
- 111887 IR3535® (Insect repellent 3535) 3-[N-n-butyl-N-acetyl] aminopropionic acid ethylester
- 106940 Oxynex® 2004 Cosmetic antioxidant formulation for fats and oils
- 117324 Colorona® Dark Blue
- 108324 Oxynex® K Liquid Cosmetic antioxidant formulation for fats and oils
- 117487 Colorona® Emerald
- 132330 Oxynex® L-CV Liquid Cosmetic antioxidant formulation for fats and oils
- 132346 Oxynex® LM-CV Cosmetic antioxidant formulation for fats and oils
- 117284 Colorona® Fine Gold MP-20
- 130217 Oxynex® ST Liquid
- 116079 Potassium Thioglycolate Solution About 42% (about 30% thioglycolic acid)
- 117050 Colorona® Glitter Bordeaux
- 117051 Colorona® Glitter Bronze
- 117053 Colorona® Glitter Copper
- 117221 Colorona® Gold Plus MP-25
- 108885 Zinc sulfide tablets about 1.5 g (ZnS) Patinal®
- 108869 Zinc selenide pieces less than 2 cm (ZnSe) Patinal®
- 104872 Potassium dihydrogen phosphate Optipur®
- 139559 Sodium Iodide Optipur®
- 105821 Magnesium fluoride pieces less than 25 mm Optipur®
- 116715 Magnesium fluoride pieces
- 105689 Lithium fluoride Optipur®
- 107386 Lead(II) fluoride Optipur®
- 101705 Barium fluoride Optipur®
- 800892 - TRIETHYL ORTHOFORMATE FOR SYNTHESIS
- 107876 - STRONTIUM HYDROXIDE OCTAHYDRATE PURE
- 106453 Sodium hydroxide
- 105072 di-Potassium oxalate monohydrate
- 139533 Potassium hydroxide
- 105949 - MANGANESE(II) NITRATE TETRAHYDRATE
- 800891 - ETHYL FORMATE FOR SYNTHESIS
- 102534 - COBALT(II) NITRATE HEXAHYDRATE PURE
- 101740 - BARIUM PEROXIDE ANHYDROUS HEAVY
- 103791 - AMMONIUM IRON(II) SULFATE HEXAHYDRATE EXTRA PURE
- 117762 Colorona® Imperial Citrine
- 117760 Colorona® Imperial Topaz
- 117403 Colorona® Karat Gold MP-24
- 117323 Colorona® Light Blue
- 117389 Colorona® Magenta
- 117190 Colorona® Majestic Green
- 117260 Colorona® Mica Black
- 117237 Colorona® Beige
- 117458 Colorona® Passion Orange
- 117490 Colorona® Purple
- 117288 Colorona® Patina Gold
- 117289 Colorona® Patina Silver
- 117322 Colorona® Red Brown
- 117320 Colorona® Red Gold
- 117271 Colorona® Russet
- 117193 Colorona® RY
- 117377 Colorona® Sienna
- 117386 Colorona® Sienna Fine
- 117223 Colorona® Sun Gold Sparkle MP-29
- 117782 Colorona® SynBerry Pink
- 117757 Colorona® SynBronze
- 117761 Colorona® SynCopper
- 117754 Colorona® SynCranberry
- 117771 Colorona® SynGold
- 117089 Colorona® Tangerine Orange
- 117489 Colorona® Ochre
- 117287 Colorona® Transgold MP-28
- 117076 Ronastar® Aqua Sparks
- 117716 Ronastar® Blue
- 117045 Ronastar® Blue Sparks
- 117783 Ronastar® Copper Jewel
- 117047 Ronastar® Copper Sparks
- 117790 Ronastar® Diamond Black IQ
- 117233 Ronastar® Flaming Lights
- 132262 RonaCare® 4-Methoxybenzoic Acid
- 101015 RonaCare® Allantoin
- 117229 Ronastar® Frozen Jewel
- 117714 Ronastar® Gold
- 117758 Ronastar® Golden Jewel
- 101072 RonaCare® Aluminium Chloride Hydroxide Allantoin
- 117231 Ronastar® Golden Lights
- 130163 RonaCare® AP
- 117042 Ronastar® Golden Sparks
- 117772 Ronastar® Green Sparks
- 110154 RonaCare® ASC III®
- 117459 Ronastar® Noble Sparks
- 117075 Ronastar® Purple Sparks
- 117715 Ronastar® Red
- 117472 Ronastar® Red Sparks
- 130153 RonaCare® Benzyl Alcohol
- 117713 Ronastar® Silver
- 130221 RonaCare® Biotin Plus
- 117457 Timiron® Arctic Silver
- 117266 Timiron® Diamond Cluster MP-149
- 117741 Timiron® Glam Silver
- 117224 Timiron® Gleamer Flake MP-45
- 130170 RonaCare® Bisabolol nat.
- 117228 Timiron® Halo White
- 117740 Timiron® Ice Crystal
- 117021 Timiron® Liquid Silver
- 117215 Timiron® Pearl Flake MP-10
- 117216 Timiron® Pearl Sheen MP-30
- 117241 Timiron® Silk Blue
- 117239 Timiron® Silk Gold
- 117242 Timiron® Silk Green
- 117240 Timiron® Silk Red
- 117470 Timiron® Snowflake MP-99
- 117476 Timiron® Splendid Blue
- 117478 Timiron® Splendid Copper
- 117474 Timiron® Splendid Gold
- 117477 Timiron® Splendid Green
- 117475 Timiron® Splendid Red
- 117479 Timiron® Splendid Violet
- 117392 Timiron® Starlight Gold
- 117383 Timiron® Starlight Red
- 117200 Timiron® Starluster MP-115
- 117186 Timiron® Super Blue
- 116413 Substance H2 granules about 1-4 mm Patinal®
- 115591 Substance H4 granules about 0.1-2 mm Patinal®
- 109952 Substance M3 granules about 1-4 mm Patinal®
- 109941 Substance M2 granules about 1-4 mm Patinal®
- 108333 Substance M1 granules
- 108332 Substance H4 granules about 1-4 mm Patinal®
- 108302 Substance M2 granules about 0.1-2 mm Patinal®
- 102437 Substance H4 HD granules about 0.8-4 mm Patinal®
- 101835 Substance L5 granules about 1-2 mm Patinal®
- 100871 Substance H1 tablets plano-convex, about 6.5 g Patinal®
- 100237 Substance H8 granules about 1-4 mm Patinal®
- 100231 Substance L5 HD granules about 1-2 mm Patinal®
- 100230 Substance H4 HD granules about 0.1-2 mm Patinal®
- 116967 Titanium oxide S
- 116828 Titanium oxide S granules about 1-4 mm (TiO₁.₇) Patinal®
- 116700 Titanium oxide S Pellets (TiO₁.₇) Patinal®
- 116440 Yttrium oxide granules about 1-2.5 mm (Y₂O₃) Patinal®
- 116011 Aluminium oxide
- 115345 Aluminium oxide granules about 1-3 mm (Al₂O₃) Patinal®
- 115337 Silicon dioxide granules about 2.5-4 mm (SiO₂) Patinal®
- 111771 Titanium(IV) oxide tablets black, about 2 g (TiO₂) Patinal®
- 111626 Hafnium(IV) oxide UV granules grey, about 1-4 mm (HfO₂) Patinal®
- 111529 Hafnium(IV) oxide UV discs about 6 g (HfO₂) Patinal®
- 111480 Zirconium(IV) oxide discs
- 110553 Silicon monoxide granules about 4-8 mm (SiO) Patinal®
- 110203 Titanium(III) oxide tablets about 1 g (Ti₂O₃) Patinal®
- 108907 Zirconium(IV) oxide tablets grey, about 1 g (ZrO₂) Patinal®
- 108905 Zirconium(IV) oxide discs grey, about 6 g (ZrO₂) Patinal®
- 108902 Zirconium(IV) oxide tablets grey, about 6 g (ZrO₂) Patinal®
- 108500 Tantalum(V) oxide granules about 1-4 mm (Ta₂O₅) Patinal®
- 108172 Tantalum(V) oxide tablets about 0.5 g (Ta₂O₅) Patinal®
- 108044 Silicon dioxide granules about 1-2.5 mm (SiO₂) Patinal®
- 107724 Silicon monoxide
- 107716 Silicon monoxide granules about 2-4 mm (SiO) Patinal®
- 107537 Silicon dioxide granules about 1-4 mm (SiO₂) Patinal®
- 117358 Timiron® Super Copper
- 117217 Timiron® Super Gold
- 117185 Timiron® Super Green
- 117187 Timiron® Super Red
- 117294 Timiron® Super Silver
- 117219 Timiron® Super Silver Fine
- 117359 Timiron® Super Violet
- 117201 Timiron® Supersheen MP-1001
- 117203 Timiron® Supersilk MP-1005
- 117764 Timiron® SynBeam Copper
- 117763 Timiron® SynBeam Gold
- 117765 Timiron® SynBeam Red
- 117767 Timiron® SynBeam Violet
- 117733 Timiron® Synwhite 40
- 117770 Timiron® SynWhite Satin
- 117226 Timiron® Ultraluster MP-111
- 117165 Xirona® Caribbean Blue
- 117499 Xirona® Golden Sky
- 117116 Xirona® Kiwi Rose
- 117728 Xirona® Le Rouge
- 117114 Xirona® Magic Mauve
- 117746 Xirona® Moonlight Sparks
- 117112 Xirona® Nordic Sunset
- 117469 Xirona® Volcanic Fire
- 117736 Xirona® Volcanic Sparks
- 132722 RonaCare® Zinc Sulfate
- 130148 RonaCare® Zinc Oxide
- 130201 RonaCare® VTA
- 132286 RonaCare® Urea cryst.
- 130133 RonaCare® Urea beads
- 132386 RonaCare® Tromethamine
- 102343 RonaCare® Cetrimonium Bromide
- 132120 RonaCare® Sodium Hydroxide
- 132398 RonaCare® Cyclopeptide-5 alcoholfree
- 132287 RonaCare® Sodium Hydroxide Solution about 32%
- 102340 RonaCare® CPC
- 132260 RonaCare® Sodium Chloride
- 130176 RonaCare® Sodium Benzoate
- 130198 RonaCare® Cyclopeptide-5
- 132285 RonaCare® Di-Sodium Hydrogen Phosphate
- 132261 RonaCare® Salicylic Acid extra pure
- 132277 RonaCare® RenouMer
- 130200 RonaCare® Ectoin
- 132144 RonaCare® Potassium Sorbate
- 132232 RonaCare® Potassium Hydroxide
- 132149 RonaCare® Poppy SE
- 130179 RonaCare® Nicotinamide
- 130204 RonaCare® Luremin®
- 132318 RonaCare® MAP
- 132219 RonaCare® Magnesium Sulfate
- 102484 Chromium(III) oxide powder less than 0.3 mm (Cr₂O₃) Patinal®
- 101759 Niobium(V) oxide granules
- 101058 Aluminium oxide granules about 1-5 mm (Al₂O₃) Patinal®
- 100840 Aluminium oxide granules about 1 - 2 mm (Al₂O₃) Patinal®
- 111807 Chromium granules about 1-4 mm (Cr) Patinal®
- 102486 Chromium
- 101502 Silver granules about 1-4 mm (Ag) Patinal®
- 115195 Substance WR1 tablets 0.03 Patinal®
- 107683 Substance WR1 tablets 0.13 Patinal®
- 101822 Substance WR4-SF tablets Patinal®
- 115377 Magnesium fluoride
- 110261 Magnesium fluoride LO granules about 1-4 mm (MgF₂) Patinal®
- 108707 Yttrium fluoride granules less than 1 mm (YF₃) Patinal®
- 107388 Lead(II) fluoride
- 107014 Gadolinium fluoride granules
- 106739 Neodymium fluoride granules about 1-4 mm (NdF₃) Patinal®
- 106457 Cryolite granules about 1-4 mm (Na₃AlF₆) Patinal®
- 105849 Magnesium fluoride granules about 0.3-1 mm (MgF₂) Patinal®
- 105845 Magnesium fluoride granules about 1-4 mm (MgF₂) Patinal®
- 105843 Magnesium fluoride
- 105834 Magnesium fluoride granules about 2.5-4 mm (MgF₂) Patinal®
- 105823 Magnesium fluoride granules about 1-2.5 mm (MgF₂) Patinal®
- 102269 Cerium(III) fluoride granules about 1-4 mm (CeF₃) Patinal®
- 101601 Ytterbium fluoride granules less than 1.6 mm (YbF₃) Patinal®
- 101600 Aluminium fluoride granules about 1-4 mm (AlF₃) Patinal®
- 101129 Lanthanum fluoride granules about 1-3 mm (LaF₃) Patinal®
- 115031 Black A powder less than 0.3 mm Patinal®
- 108322 Substance L5 granules about 0.5-4 mm Patinal®
- 140817 Iriotec® 9230
- 141499 Iriodin® 96111 SW Icy White Pristine
- 107688 Silicon dioxide granules about 1-3 mm (SiO₂) Patinal®
- 158069 Xirallic® T50-10 Crystal Silver
- 158254 Xirallic® NXT F250-51 Cougar Red
- 132354 RonaCare® Malic Acid
- 117262 Ronastar® Red Lights
- 585110 Durazane® 2800
- 158266 Xirallic® NXT M260-70 SW Amur Black
- 141600 Meoxal® F120-51 CWT Victoria Red
- 141481 Iriodin® 6163 WAY
- 117268 RonaFlair® Satin
- 158264 Xirallic® NXT T250-23 Tigris Blue
- 120625 Candurin® NXT Silver Blossom
- 141520 Iriotec® 8855
- 132376 RonaCare® Balmance
- 141478 Iriodin® 103 WAY
- 158241 Xirallic® NXT M250-30 Leonis Gold
- 158242 Xirallic® NXT T260-23 WNT Tigris Blue
- 117280 Ronastar® Blue Lights
- 141530 Biflair® 81
- 141535 Iriotec® 8817
- 132400 RonaCare® Ectoin IQ
- 141547 Lumixir® Solitaire GBM071
- 132377 RonaCare® Epintegrity
- 102697 High vacuum oil Aneron®
- 141541 Iriotec® 7312
- 132420 RonaCare® Hibiscus
- 132419 RonaCare® Baobab
- 117722 Ronastar® Blue Sparks SQ
- 132427 Eusolex® Z-BASE
- 132428 Eusolex® Z-TEC
- 117720 Ronastar® Noble Sparks SQ
- 117721 Ronastar® Golden Sparks SQ
- 117723 Ronastar® Copper Sparks SQ
- 117726 Ronastar® Red Sparks SQ
- 117759 Ronastar® Golden Jewel SQ
- 117784 Ronastar® Copper Jewel SQ
- 130205 Dihydroxymethylchromone
- 117286 RonaFlair® Infinity
- 117779 RonaFlair® Boroneige® SQ-6
- 132429 Eusolex® 232 USC
- 494189 1-Ethyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide No commitment to mass production, for R&D only Solarpur®
- 494800 1-Propyl-2,3-dimethyl-imidazolium iodide No commitment to mass production, for R&D only Solarpur®
- 117415 Colorona® Treasure Gold
- 141549 Iriotec® 8212
- Colorstream® F20-52 SW Mineral Red
- 117372 Ronaflux® Foxy Red
- 117368 Ronaflux® Peacock
- 117371 Ronaflux® Specular Green
- 117370 Ronaflux® Specular Blue
- 117369 Ronaflux® Specular Silver
- 132484 RonaCare® Caffeine
- 117387 Xirona® Le Coeur
- 117282 RonaFlair® Luminous Glow
- Our R&D Approach
- Biopharma-Pipeline
- Healthcare Pipeline
- Global R&D Hubs
- Artificial Intelligence - AI Research
- Global Health Institute
-
- Pipeline & Initiatives
- The Team
- News
-
- Global Health Collaboration: Development of a new schistosomiasis diagnostic tool
- Our company supports healthcare workers fighting Covid-19 in Cameroon
- Path to Zero Malaria for prevention and cure of this deadly disease
- Artificial Intelligence: Merck KGaA, Darmstadt, Germany, to develop automated Diagnostic Tool for Neglected Tropical Diseases together with Janssen
- Global Health in times of Covid-19
- World Malaria Day: Zero Malaria Starts With Merck KGaA, Darmstadt, Germany
- World Health Day 2020 – Our Global Health Institute supports Nurses and Midwives
- Data-driven approach guides our Global Health programs
- World Water Day: Access to Clean Water Program
- Transmission control as a key component in the fight against schistosomiasis
- Merck KGaA, Darmstadt, Germany, actively fights falsified medicines
- Merck KGaA, Darmstadt, Germany, as a reliable partner in Global Health
- Pediatric Praziquantel Formulation Program: First patient dosed in Phase III clinical trial
- We are onboarding an asset against a Neglected Tropical Worm disease from Salvensis and the London school of Hygiene & Tropical Medicine.
- Pediatric Praziquantel Consortium: Taking the next step towards access with continued support from the GHIT Fund
- Today is World Malaria Day!
- We are partnering with FIND to develop a Rapid Diagnostic Test (RDT) for schistosomiasis
- Neglected Tropical Diseases: Important dialogues with local communities and experts led by our company
- Letter from Jutta Reinhard-Rupp, Head of the Global Health Institute
- Consortium Pediatric Praziquantel Program successfully completed Phase II in Ivory Coast
- R&D holds 2nd place in the Access to Medicine Index 2018
- Global Health Institute contributing to the definition of upcoming Target Product
- Our company at International, Scientific Meetings for Global Health
- The ESCARGOT Project: Fighting Schistosomiasis through Innovation
- Performance Materials: Key Player towards the success of the Consortium Pediatric Praziquantel Program
- Hosting African fellows: A Success Story
- Merck KGaA, Darmstadt, Germany, played a leading role in Brazil events on schistosomiasis
- The Merck KGaA, Darmstadt, Germany, “Power of We” at the service of children suffering from Malaria in Ghana
- The International Schistosomiasis Community will celebrate the Global Health Institute in Brazil
- Path to Zero Malaria in the front seat at the 7th MIM (Multilateral Initiative on Malaria) Pan-African Malaria Conference
- The Global Health Institute presenting at the ‘International Society of Neglected Tropical Diseases (ISNTD) Festival’ in London
- The Global Health Institute featured at the 2018 World Health Assembly luncheon on Schistosomiasis
- Our company supports the World Malaria Day 2018
- The Global Health team represented at the Geneva Health Forum 2018
- University of Cape Town and Medicines for Malaria Venture join forces to feed the antimalarial pipeline
- The Global Health Institute engages with the Global Health Community
- EDCTP and GHIT Fund co-fund the development of the pediatric Praziquantel formulation for schistosomiasis
- Joining forces to advocate about Female Genital Schistosomiasis and its impact on HIV